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CHAPTER1: GENERAL INTRODUCTION 
Introduction 
 
The global population is predicted to expand from the current size to an 
estimated 7 billion to 9.1 billion by 2050. Aquatic food products, the fastest growing 
of the food-producing sectors, are predicted to supply more than 50% of this sector 
by 2015 (Stentiford et al. 2012). The aquaculture industry continues to grow rapidly, 
particularly in the case of cultured marine shrimp. Indeed, cultured shrimp harvest 
was an estimated 3.5 million metric tons representing a sale value of $14.6 billion 
USD in 2009 (Moss et al. 2012). In the early era of shrimp farming expansion 
(1970s-1980s), Penaeus monodon was the major in culture species, and the 
industry relied on wild caught stocks to produce postlarvae (PL) and adult 
broodstock to supply seed for the industry (Moss et al. 2012). However, this is a 
high-risk practice because wild-caught animals can be carriers of diseases that then 
can be introduced into culture facilities. The industry largely has shifted from using 
wild seed stocks of P. monodon to using specific pathogen-free (SPF) domesticated 
lines of Litopenaeus vannamei, a North American species. L. vannamei was 
introduced to Asian crustacean fisheries in the late 1990s and soon became the 
dominant species in Asia and other shrimp farming regions (Flegel 2012, Lightner et 
al. 2012). Aquaculture practices have also changed from a traditional extensive 
farming to semi-intensive or intensive systems that are more efficient production 
systems. The adoption of L. vannamei in culture systems worldwide, along with 
effective biosecurity measures and intensive farming techniques, have resulted in 
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rapid growth of the global shrimp farming industry over the last four decades (Flegel 
2012, Moss et al. 2012). This growth has been hampered only by pandemic viral 
diseases that have devastated harvests and yields; therefore, they have also greatly 
impacted the economics of the shrimp industry worldwide (Flegel 2012, Lightner et 
al. 2012). Thus, development of strategies to prevent and control viral diseases is of 
tremendous interest and importance for the sustainability of this industry.  
The research described in this dissertation emphasizes two virus pathogens: 
1) Infectious myonecrosis virus (IMNV) and 2) White spot syndrome virus (WSSV) 
that have caused more than $16 billion in losses combined since the first outbreaks 
(Lightner et al. 2012). The first manuscript of this dissertation describes the 
characterization of newly revealed sequences in the IMNV genome. This paper 
provides evidence that additional sequences exist in the IMNV genome, resulting in 
an overall genome length that is 8226 base pairs (bp) as compared to the original 
description of 7561 bp. The second manuscript describes variation in virulence in 
geographically distinct isolates of IMNV from Brazil and Indonesia. The third 
manuscript describes the utilization of RNAi to silence WSSV by targeting early gene 
expression and that is more effective at suppressing virus replication than 
suppressing late genes. This result provides a new target antiviral for WSSV. The 
fourth manuscript presents the development of direct delivery methodology of 
double-stranded RNA (dsRNA) into the foregut lumen of L. vannamei. This 
manuscript indicates that delivery of dsRNA by reverse gavage elicits protection that 
is comparable to intramuscular injection methods, and provides evidence that shrimp 
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possess some mechanism to uptake dsRNA from the gut lumen. This method can 
be used as a proxy for possible per os vaccination trials. 
Dissertation Organization 
This dissertation is organized in manuscript format. Chapter 1 includes a brief 
introduction to a topic followed by a literature review with a general background of 
IMNV and WSSV, current knowledge of RNA interference (RNAi), shrimp immunity 
and augmenting RNAi to control virus diseases. Chapter 2, 3, 4, and 5 are 
manuscripts describing the research and results obtained by the primary research 
author, Duan Loy, and co-authors. Chapter 6 provides general conclusions of the 
research, discussion of future work followed by an acknowledgements section. 
Literature Review 
History of Infectious myonecrosis virus (2002-2013) 
An unknown disease outbreak described as “cotton shrimp disease” was 
reported in a Pacific white shrimp farm, L. vannamei, in northeastern Brazil in 2002 
(Poulos et al. 2006). The infected shrimp were initially thought to be infected with a 
microsporidian parasite due to the gross signs of white abdominal muscle in the 
shrimp. Some of the animals were submitted to the Office International des 
Epizooties (OIE) reference laboratory for shrimp diseases at the University of 
Arizona. The samples were processed for histopathology and PCR/ RT-PCR and 
results showed that the shrimp samples were not infected with microsporidia or other 
known viruses (Andrade 2009). The clinical signs of disease are white and opaque 
muscle, specifically at the distal abdominal segment and tail fan. Infected animals 
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are lethargic and have reduced feed consumption. The feed conversion ratio (FCR) 
in infected ponds rose from 1.5 to 4.4 and the survival rate decreased to as low as 
21%. The disease progressed slowly throughout the culture season and the overall 
mortality rate ranged from 40-70%. In addition to L. vannamei, P. monodon, 
Litopenaeus stylirostris and Farfantepenaeus subtilis are susceptible to IMNV 
infection (Tang et al. 2005, Coelho et al. 2009). IMNV transmission occurs 
horizontally by ingestion of infected tissue from dead or moribund shrimp.  
The disease was then spread through shrimp farming areas across Brazil. At 
the end of 2005, it was estimated that shrimp farms in Brazil suffered $440 million 
USD of economic losses as a result of this disease (Andrade et al. 2007). The 
etiologic agent was described and named Infectious myonecrosis virus (IMNV) 
(Lightner 2004). Due to the significant impact that IMNV could have on disease free 
countries, IMNV was listed by the OIE as a pathogen and reportable disease in 
2005. The OIE is an international organization that functions to inform governments 
of the emergence of disease and develop the control measurements for those 
diseases. Unfortunately, IMNV emerged in East Java in Indonesia in 2006. The 
genomes of IMNV isolates from Indonesia and Brazil share 99.6% identity at the 
nucleotide (nt) level (Senapin et al. 2007). The translocation of IMNV was probably 
through unregulated transportation of live animals (Flegel 2006, Senapin et al. 2007, 
Walker & Mohan 2009), and the virus subsequently spread to other regions of the 
country. Financial losses in these two endemic countries was estimated at more 
than $1 billion USD (Lightner et al. 2012). IMNV outbreaks in other countries have 
not yet been reported. Rumors of disease outbreaks in other Asian countries such 
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as Thailand and China have circulated periodically due to the similar clinical signs of 
white muscles (Senapin et al. 2011, Yan et al. 2013). However, white muscles can 
be caused by muscle cramp syndrome, stress factors, penaeid white tail disease 
(Penaeus vannamei Nodavirus) and white tail disease of Macrobrachium rosenbergii 
(Nodavirus) (Tang et al. 2007, Bonami & Sri Widada 2011, Senapin et al. 2011). 
IMNV disease has to be confirmed by an OIE approved, standard diagnostic 
techniques.  
IMNV disease etiology and genome characterization 
IMNV was classified in the member of family Totiviridae based on 
phylogenetic analysis of the RNA dependent RNA polymerase (RdRp) coding 
region; this revealed that IMNV is most closely related to Giardia lamblia virus 
(GLV). Fungi and protozoa that are infected with totiviruses, such as 
Saccharomyces cerevisiae virus (ScV) and GLV, typically are asymptomatic and the 
virus is persistent. Most viruses in the family Totiviridae are transmitted to new cells 
only during cell division, sporogenesis and cell fusion (Poulos et al. 2006). GLV, 
IMNV and Piscine myocarditis virus (PMCV) exhibit extracellular transmission, which 
is different from other viruses in family Totiviridae. IMNV and PMCV are unique 
amongst the Totivirus genus because they infect penaeid shrimp and Atlantic 
salmon (Salmo salar L.), respectively (Haugland et al. 2011) as opposed to other 
viruses in Totiviridae family that infect fungi and protozoa (Tang et al. 2008). These 
two viruses cause significant pathological changes in muscle that can be observed 
by histopathology. IMNV replicates in the cytoplasm of muscle cells as demonstrated 
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by in situ hybridization (Poulos et al. 2006), resulting in gross signs that are easily 
observed as opaque muscle in the abdominal segments. 
IMNV is non-segmented, non-enveloped, double-stranded RNA (dsRNA) and 
the virus particle is icosahedral with a 40 nm diameter. The initial report of IMNV 
genomes of both strains indicated the genome size 7561 bp (NC007915.2, 
AY570982.2; EF061744.1), which is composed of ORF1 and ORF 2. The putative 
ORF 1 (nt 136-4953) encodes a protein with a dsRNA-binding motif (DSRM) (nt 136-
315, 60 amino acids (aa)) and a major capsid protein (MCP) (nt 2248-4953, 901 aa). 
The putative ORF 2 (nt 5241- 7490) encodes RNA-dependent RNA polymerase 
(RdRp) (nt 5241-7490, 749 aa) (Senapin et al. 2007). Additional studies revealed 
that 2A-like cleavage and a shifty heptamer of ORF1 produce polyprotein products; 
protein 1, protein 2 and protein 3 (Nibert 2007). The functions of these proteins 
remain unclear (Poulos et al. 2006, Nibert 2007). The study used cryomicroscopy 
and 3D imaging to further characterize the virion structure. The results demonstrate 
the protrusion fibers form five-fold axes that may play a role in facilitating 
extracellular transmission and pathogenesis of IMNV (Tang et al. 2008). A recent 
study showed that the laminin receptor (Lamr) is a proposed virus receptor because 
it interacts with the capsid protein of IMNV based on a yeast two-hybrid screen 
(Busayarat et al. 2011). Further studies are needed to have a better understanding 
of the infection mechanisms of IMNV. The initial description of the IMNV genome 
included 7561 bp; however, our subsequent study revealed that the IMNV genome is 
larger in size (8226 bp) and therefore has an expanded protein coding capacity. The 
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addition of this novel sequence changes our understanding of the IMNV genome 
organization and provides novel insight into IMNV biology. 
IMNV diagnostic methods  
The clinical signs of white muscle in penaeid shrimp can be caused by 
infectious and non-infectious disease. A standardized diagnostic technique is 
necessary to differentiate from disease caused by stress, hypoxia or other infectious 
agents. The diagnostic methods approved by the OIE (2012), include 
histopathology, antibody-based antigen detection (Kunanopparat et al. 2011) and 
molecular techniques (quantitative real-time RT-PCR, nested RT-PCR and in-situ 
hybridization). Infected muscle tissue can be used to detect virus load by qRT-PCR 
(Andrade et al. 2007). Histopathological lesions are evident in infected tissue, 
particularly in striated muscle (skeletal muscle and less frequently in cardiac 
muscle), connective tissue, hemocytes and lymphoid organ parenchymal cells. The 
histopathological changes appear as myonecrosis with some infiltration and 
accumulation of hemocytes (blood cells). Intracytoplasmic, dark basophilic inclusion 
bodies are seen within the muscles cells, hemocytes and connective tissue cells. 
The lymphoid organ (LO) also shows significant histopathological changes. During 
IMNV infection, the LO is hypertrophied and spheroids are commonly found (Poulos 
et al. 2006, Loy et al. 2012). In addition to laboratory diagnostics, a pond-side 
immunochromatographic test strip detection method has been developed to for 
IMNV infection. This technique uses a monoclonal antibody specific to the capsid 
protein of IMNV. The IMNV strip test is 300-fold less sensitive than one-step RT-
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PCR; however, it is inexpensive and user-friendly for farmers (Chaivisuthangkura et 
al. 2013).  
IMNV disease prevention and control measurements 
There are no methods to effectively prevent and control outbreaks of IMNV in 
the field. However, studies have shown that administering sequence-specific RNAi 
antiviral molecules result in significantly reduced pathology and virus load in infected 
animals (Loy et al. 2012). These data prompted us to put forth the argument that 
sequence-specific, optimized dsRNA functions as a vaccine to prevent infection and 
disease caused by IMNV (Bartholomay et al. 2012). Moreover, these dsRNA 
constructs can be utilized as a therapeutic antiviral treatment against IMNV when 
administered post-infection. Administration of 0.5 µg/shrimp of dsRNA194-275 48 
hours following IMNV injection resulted in at least 50% survival compared to other 
treatment groups (Loy et al. 2013). Although these are promising and provocative 
results, exploiting RNAi as a disease control method in the field is in the 
developmental phase; thus the use of more basic prevention strategies to control 
and prevent viral disease is essential. These include use of Specific Pathogen Free 
(SPF) animals, farm biosecurity and family-based selection to breed for disease 
resistance (Moss et al. 2012). Using SPF animals with biosecurity measures on 
farms is a more promising means to reduce the risk of IMNV outbreaks because 
breeding for IMNV resistance thus far has been minimally successful. Based on 
anecdotal evidence, selective breeding for IMNV resistance shows significant 
improvement in survival, from 3.2% in the F1 generation to 55.3% in F7 (White-
Noble et al. 2010). However, these data have not been published in the peer-
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reviewed literature and the selection process was conducted using IMNV (Brazil) 
(Lima et al. 2013) so studies are needed to determine if the IMNV resistant line is 
equally resistant to IMNV (Indonesia).  
White spot syndrome virus: The most devastating virus to the shrimp industry 
White Spot Disease (WSD) was first described in China and Taiwan in 1992 
and1993. Subsequently, the disease spread quickly throughout Asia including 
Japan, Korea and Thailand (Chou et al. 1995, Wongteerasupaya et al. 2003, Walker 
& Mohan 2009). WSD later emerged in the United States and was reported in South 
Texas in 1995, probably as a result of imported frozen-bait shrimp products from 
Asia (Hasson et al. 2006). Outbreaks of WSD were also found in other shrimp 
farming areas including South, North and Central America, Europe and the Middle 
East (Leu et al. 2009, Walker & Mohan 2009, Sanchez-Paz 2010, Lightner et al. 
2012). To date, WSSV is the most contagious virus in shrimp aquaculture and it 
causes the highest economic losses of all infection shrimp diseases. The economic 
impact of WSD is estimated at more than $15 billion (Lightner et al. 2012). WSD is 
highly virulent and causes up to 100% mortality within 3-7 days of infection. White 
spots (ranging from 0.5-3.0 mm in diameter) can be observed on the carapace, 
appendages and epidermis of infected animals; however, these signs are not a 
definitive diagnostic because white spots also are caused by high alkalinity, bacterial 
infection and other environmental stressors (Leu et al. 2009). Other clinical signs are 
reddish-pinkish discoloration, lethargy and reduced feed intake. WSSV can infect a 
wide-host range of aquatic crustaceans including crabs and crayfish that can serve 
as reservoir hosts in the natural environment. Other invertebrates such as copepods, 
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artemia and polychaetes also can serve as a mechanical vectors of WSSV infection 
(Walker & Mohan 2009). Other WSSV hosts both natural and experimental infection 
has been reviewed by Sanchez-Paz (2010). WSSV has a wide range of tissue 
tropisms of infected shrimp including tissue of ectodermal (cuticular epidermis, 
foregut, hindgut, gills, nervous system) and mesodermal (lymphoid organs, 
connective tissue, antennal glands) origins. Virus replication occurs in the nucleus 
causing nuclear hypertrophy, nuclear dissolution and chromatin margination. 
Infection results in an intranuclear eosinophilic Cowdry A-type inclusions, i.e., 
amorphous clear halos within the nuclear membrane (Leu et al. 2009).   
White spot disease etiology  
WSSV is a large (80-120x250-280 nm) rod to elliptical-shaped, double-
stranded DNA, enveloped virus with unique tail-like appendages at one end. The 
virus genome is circular, approximately 300 kbp with at least 181 ORF. In initial 
reports, WSSV was classified as a non-occluded baculovirus, but later evidence 
showed that WSSV is a new virus (van Hulten et al. 2001) and within its own genus 
(Whispovirus) and is not related to baculoviruses (Fauquet 2005). The WSSV 
genome has been completely sequenced from three WSSV isolates from China, 
Thailand and Taiwan (accession no. AF332093, AF369029 and AF440570, 
respectively) which share 99.3% nt identity (Sanchez-Paz 2010). The virion is 
composed of at least 45 structural proteins that are arranged into three layers 
including the nucleocapsid, tegument and envelope. The nucleocapsid is a helical, 
baciliform structure that contains the dsDNA genome and nine proteins including, for 
example, VP15, a basic DNA-binding protein, and VP664 that forms a stack ring unit 
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in the tegument layers. The tegument layer is in-between the nucleocapsid and 
envelope and is composed of at least four structural proteins, including VP26. The 
envelope layers comprise at least 28 structural proteins such as VP19 and VP28. 
WSSV genes are classified according to temporal gene expression in three phases 
including immediate-early (IE), early (E) and late (L) genes. Viral IE genes can be 
expressed independently during the early stage of infection, approximately 2 hours 
post-primary infection (Liu et al. 2005). Viral E genes usually encode regulatory 
proteins which are necessary for L gene expression (Han et al. 2007). Viral L genes 
are expressed in the late stage of infection, i.e., at least 16-24 hours post-infection 
(Leu et al. 2009, Sanchez-Paz 2010). 
There is a desperate need for measures to control and prevent outbreaks of 
WSSV. In addition to SPF stocks and farm biosecurity, WSSV resistance breeding 
programs have been under development for decades with limited success (Lightner 
et al. 2012). Research efforts on developing vaccines to mitigate WSD have 
employed recombinant proteins, DNA- and RNAi-based strategies, all primarily 
targeting structural genes (Westenberg et al. 2005b, Vaseeharan 2006, Rout et al. 
2007, Wu et al. 2007b, Attasart et al. 2009). We postulated that an RNAi strategy 
that targets immediate early or early genes may be more effective at shutting down 
virus replication earlier in the infection process and thereby reduce disease burden. 
This was tested and described in Chapter 4. 
Shrimp immunity 
Immunity is a state in which the body is protected from pathogens and other 
toxic substances as a result of the coordinated effects of cells and molecules that 
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are involved in innate or adaptive immune responses. Generally speaking, innate 
immunity manifests as the first-line of defense mechanisms that acts immediately 
(i.e., within minutes or hours) to destroy invading organisms in a non-specific 
manner. Innate immune responses do not rely on induction and expansion of 
antigen-specific lymphocytes as do adaptive responses, so do not directly generate 
canonical immunological memory, although innate immunity does impact adaptive 
immunity in organisms that have both innate and adaptive immunity (Maclachlan et 
al. 2011, Tizard 2013). 
The innate defense system of arthopods, including crustaceans, is 
characterized as strictly innate in nature, with humoral and cellular effector arms. 
Humoral responses include clotting and prophenoloxidase cascades, and 
antimicrobial peptides. Shrimp have an open circulatory system that consists of 
plasma called hemolymph and blood cells called hemocytes. Hemocytes play an 
important role in the immune response of shrimp against infection (Jiravanichpaisal 
et al. 2006). Cellular immune responses include apoptosis, encapsulation, 
phagocytosis and melanization (Little et al. 2005, Tassanakajon et al. 2013). Shrimp 
utilize both humoral and cellular responses to combat pathogen infection (Bachere 
et al. 2004, Wang & Zhang 2008).  
Innate immune responses in shrimp are initiated when pathogen-associated 
molecular patterns (PAMP) are recognized by pattern recognition receptors (PRR). 
The interaction of these molecules triggers a number of complex responses that 
involves the production of antimicrobial peptides, including the enzymes and 
inhibitors that control the activity of these peptides (Tassanakajon et al. 2013). It is 
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generally believed that invertebrates lack a complex adaptive immune response due 
to the fact that there is no evidence of antigen-specific humoral compound 
production akin to antibodies in vertebrates (Liu et al. 2009). Thus, there are no T 
cells, B cells, B cell receptors, or major histocompatibility complex molecules (MHC) 
in invertebrate immune systems (Little et al. 2005). An adaptive immune system is 
associated with immune memory, which will significantly enhance the ability to 
mitigate disease during the second and subsequent infections (Tizard 2013). There 
are data from shrimp and other arthropods that demonstrate that invertebrates 
possess some form of memory immune response but the precise underlying 
mechanisms are poorly understood (Little et al. 2005). Recently, evidence of a 
mechanism for a more specific immune response capacity has been discovered in 
crustaceans known as Down syndrome cell adhesion molecule (Dscam). Dscam, a 
member of the immunoglobulin super family (IgSF), that was identified and 
characterized in crustaceans including P. vannmei, P. monodon, Pacifastacus 
leniusculus and Eriocheir sinensis (Chinese mitten crab) (Chou et al. 2009, Chou et 
al. 2011, Watthanasurorot et al. 2011, Wang et al. 2013). The Dscam molecule has 
hyper-variable region that can facilitate phagocytosis of the specific invading 
pathogens through alternative splicing by recognizing pathogens including bacteria 
Escherichia coli, Streptococcus aureus, Vibrio alginolyticus and WSSV 
(Watthanasurorot et al. 2011, Lin et al. 2013, Wang et al. 2013). Due to the extreme 
diversity of Dscam receptors, this could be a mechanism by which unique and 
specific responses are elicited to pathogens that have a tremendous impact on 
crustacean fisheries. 
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In vertebrate innate immune system, Type I interferon (IFN) is a first line 
antiviral immune response. Interferons are glycoproteins secreted by virus-exposed 
cells that protect neighboring cells against viral infection. IFN-inducible genes 
include RNA dependent protein kinase R (PKR), the Matrix protein (Mx), 
oligoadenylate synthetase and IFN molecules themselves (Tizard 2013). Double-
stranded RNA, which is not normally produced in a cell, but occurs as function of 
virus replication and formation of extensive secondary structure in virus RNA 
sequences, is a potent inducer of an IFN response (Robalino et al. 2004, Tizard 
2013). The dsRNA is recognized by Toll-like receptor 3 (TLR3), PKR and retinoic 
acid-inducible gene I (RIG-I) (Tizard 2013). The consequences of dsRNA recognition 
include activation of the IFN system, initiation of apoptosis and inhibition of cellular 
protein synthesis to shut off virion production (Robalino et al. 2005). A Toll receptor 
has been identified in L. vannamei (lToll) (Yang et al. 2007), however the data show 
that lToll is not involved in dsRNA-induced antiviral immunity (Labreuche et al. 
2009). Because invertebrates lack genes that are homologous to IFNs or the major 
effector molecules such as protein kinase R, it has long been assumed that 
invertebrates lack the ability to mount an antiviral response. However, with the 
discovery of the RNA interference (RNAi) in the nematode, Caenorhabditis elegans 
(Fire et al. 1998), it became clear that cells detect and internalize double-stranded 
RNA (dsRNA) and then initiate intracellular gene-silencing events. Since then 
several lines of evidence have revealed that RNAi is, in fact, a robust antiviral 
immune response in invertebrates including fruit flies, mosquitoes, bees and shrimp 
(Olson et al. 2008, Hunter et al. 2010, Bartholomay et al. 2012). 
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RNA interference mechanism and function 
RNA interference or RNAi is a biological process that mediates gene silencing 
in a sequence-specific manner. The mechanism and the function of the biochemical 
molecules and events that are fundamental to a functional RNAi pathway have been 
extensively studied during the last decade. The phenomenon was first observed in 
the 1990s in flowering plants during an attempt to produce more purple coloration in 
pansies by introducing more transgene-encoding enzyme for flower pigmentation. 
Surprisingly, the flowers turned white or variegated rather than more purple as 
expected. This phenomenon was called co-suppression of gene expression (Napoli 
et al. 1990) and later was reported as posttranscriptional gene silencing (PTGS). 
Then, a related phenomenon was also observed in the fungus, Neurospora crassa 
(Pallavi et al. 2012). Andrew Fire and Craig Mello published their breakthrough study 
on the mechanism of RNAi in Caenorhabditis elegans in 1998 which showed that 
dsRNA that is introduced into worms can interfere with gene expression (Fire et al. 
1998). This discovery won the Nobel Prize in Physiology or Medicine in 2006.  
The RNAi pathway is initiated by long double-stranded RNA (dsRNA) that can 
be produced during viral replication, by integrated transposons, by the cell itself in 
the form of non-coding microRNA (miRNA), and by exogenous introduction of in vitro 
synthesized dsRNA. Following recognition, dsRNAs are processed into short 
dsRNA, siRNA or miRNA by Dicer enzymes. Dicer is an ATP-dependent RNase III-
family enzyme that is conserved in plants, fungi, and animals including mammals 
and invertebrates (Fire et al. 1998, Kim & Rossi 2008, Vijayendran et al. 2013). 
R2D2 has two dsRNA binding domains that link the initiator and effector stages of 
	   16	  
the RNAi pathway. Its function is to load Dicer/siRNA into RNA-induced silencing 
complex (RISC) complex. The passenger strand (sense strand) of the siRNA duplex 
must separate from the guide strand (anti-sense strand) before loading to RISC 
complex. Then, the passenger strand is degraded and the guide strand remains 
associated with RISC complex. The RISC complex is composed of an Argonaute 
protein (Ago) that is an endonuclease capable of degrading the complementary 
sequences of target mRNA into 21-22 fragments. Therefore, this functions as a post-
transcriptional gene silencing mechanism and inhibits protein synthesis. In particular 
systems such as plants, worms and fungi, an RNA-dependent RNA polymerase 
(RdRP) plays a critical role in maintaining and amplifying the silencing signal through 
synthesis of secondary dsRNA trigger molecules. An RdRp has not been identified 
in the genomes of either flies or humans (Olson et al. 2008, Pallavi et al. 2012). In 
the fruit fly, Drosophila melanogaster, the spread of systemic RNAi is mediated by 
endocytosis but the effect lasts only 5 days (Saleh et al. 2009). In penaeid shrimp, 
Sid-1 protein (systemic interference defective protein), a membrane channel protein 
that functions to mediate the spreading of systemic RNAi, was identified by 
Labreuche et al., (2010). The RNAi machinery characterized in penaeid shrimp also 
includes Dicer 1, Dicer 2 (Su et al. 2008, Yao et al. 2010, Chen et al. 2011), 
Argonaute 1 and Argonaute 2 (Unajak et al. 2006, Dechklar et al. 2008, Labreuche 
et al. 2010). The presence of these key RNAi pathway components further supports 
the existence of RNAi in penaeid shrimp.  
Three major classes of small regulatory RNAs have been characterized 
including: microRNA (miRNA), small interfering RNA (siRNA), and PIWI-interacting 
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RNA (piRNA). The function of each small RNA is relatively distinct but related 
proteins are required for small RNA biogenesis and function in all pathways. All 
three of these small RNA classes are involved in host-virus interactions. Small RNA 
can range from 18-32 nt in size and have distinct origins and functions. siRNA (21-
22 nt) or miRNA (18-25 nt) can be differentiated from each other based on their 
biogenesis or function (Cook & Blelloch 2013). In general, the miRNA binds target 
mRNA to inhibit translation and siRNA are thought to bind target mRNA and direct 
cleavage of a nascent transcript. The function of miRNA does not require that the 
target has a perfect match to inhibit translation. In contrast to miRNA, siRNA only 
binds to the target mRNA with identical sequence, which results in the cleavage of 
the transcript. piRNA are slightly longer (25-32 nt) and do not require Dicer for 
processing. The complete mechanism and function of producing piRNA remains 
unclear but they seem to play a role in the cellular defense against transposable 
elements and in antiviral responses in mosquitoes (Morazzani et al. 2012, 
Vijayendran et al. 2013).  
miRNAs are encoded by specific miRNA genes as a short hairpin primary-
microRNA (pri-miRNAs) approximately 60-75 nt in length in the nucleus and are first 
processed by the proteins Drosha and Pasha to pre-miRNA. Then pri-miRNAs are 
exported to cytoplasm by Exportin 5 and processed into miRNA by Dicer1 (He & 
Hannon 2004). The function of miRNA is to regulate gene expression by 
suppressing the mobilization of transposons that is important for the growth and 
development of organisms (Nykanen et al. 2001). miRNAs maintain genome stability 
by controlling transposons which are DNA sequences that can move around the 
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genome and cause deleterious effects. Transposons operate by copying their DNA 
to RNA and then reverse-transcribing back to DNA; the RNA form is usually double-
stranded so can be recognized and targeted by RNA interference (Pallavi et al. 
2012). miRNAs also are involved in regulation of larval development in C. elegans, 
growth control and apoptosis in D. melanogaster and mediating host-virus 
interactions (Vijayendran et al. 2013). miRNAs have been recently identified in the 
WSSV genome using miRNA microarray and northern blot analyses. WSSV 
encodes 40 distinct viral miRNAs and engages RNAi pathway components including 
Dicer1 and Drosha (He & Zhang 2012). The study showed that WSSV-miR-66 and 
WSSV-miR-68 are key to the establishment of WSSV infection (He et al. 2014). This 
information supports the hypothesis that miRNA are involved in virus infection in 
arthropods and play a role in host-virus interactions. 
siRNAs have been the focus of shrimp research in the last decade because 
compelling evidence shows that RNAi functions in antiviral immunity. In other 
arthropods including mosquitoes and Drosophila, the end products of RNAi or virus-
derived small interfering RNAs (vsRNAs) are present in cell culture and host tissues 
during infection (Bartholomay et al. 2012). In our laboratory, a lymphoid organ 
transcriptome analysis revealed that vsRNAs (mostly 21-22 nt) are generated during 
IMNV infection (unpublished data). Secondly, suppression of the RNAi pathway 
results in widespread virus replication and increases pathogenicity of disease. For 
example, suppressing RNAi pathway proteins such as Ago2, Dicer2 genes causes 
increasing viral titer of O’nyong-nyong virus and Sindbis virus in mosquitoes (Keene 
et al. 2004, Campbell et al. 2008, Bartholomay et al. 2012). In our laboratory, we 
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designed a study to suppress the RNAi pathway by targeting Ago2. Shrimp that 
received dsRNA to Ago2 showed mortality within 7 days post-injection without any 
virus infection (unpublished data). Labreuche et al. (2010) also reported this 
observation. Thus, the RNAi components may play a vital role in other physiological 
processes, and further research is needed to dissect the roles of these proteins. 
Finally, several arthropod-specific virus genomes encode RNAi suppressors to 
counteract the host antiviral response. For instance, Cricket Paralysis (CrPV), 
Drosophila C virus encoded 1A protein (Nayak et al. 2010) and Flock House virus 
(FHV) encoded B2 protein (Chao et al. 2005). IMNV also may encode an RNAi 
suppressor because ORF1 encodes a protein with a dsRNA binding domain (Poulos 
et al. 2006, Bartholomay et al. 2012).  
Augmenting RNAi to affect disease control 
RNA interference (RNAi) technology was declared the “Scientific 
Breakthrough of the Year” in 2002 in the journal Science because this is a tool that 
can be used to breakdown mRNA and thereby inhibit protein expression (Couzin 
2002). RNAi provides a new and exciting tool for drug discovery with which putative 
drug targets can be suppressed and the biological effects observed (Leung & 
Whittaker 2005). There are a number of pharmaceutical and biotechnology 
companies developing RNAi-based pharmaceuticals and vaccines. RNAi-based 
vaccines are arguably safer as compared to modified live vaccines (MLV) that have 
been used frequently to control viral diseases. MLV have the potential to mutate to a 
virulent form and could exacerbate disease in immunosuppressed animals 
(Maclachlan et al. 2011). In contrast, RNAi-based vaccines synthesized from nucleic 
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acid (dsRNA) are more stable and can’t revert to a virulent form. In humans, RNAi 
technology has been used in clinical trials and provided promising results for treating 
several diseases such as ocular and retinal disorders, cancer, kidney disorders and 
hypercholesteremia (Davidson & McCray 2011). 
RNAi was first studied in L. vannamei by Robalino and collaborators 
(Robalino et al. 2004, Robalino et al. 2005). The discovery of this mechanism in 
shrimp was very exciting to shrimp researchers and the aquaculture industry 
because it provided a new potential tool to control virus disease outbreaks. In an 
IMNV study conducted in our laboratory, a specific dsRNA corresponding to 
nucleotides from 95-475 (dsRNA95-475), at a dose of 2 µg/shrimp, provided 81.67% 
survival protection against IMNV challenge at 2 days post-vaccination. Those 
surviving animals were re-challenged with 100X higher dose of IMNV at 52 days 
post-initial challenge. The study was followed for an additional 40 days and the 
animals showed 94% survival (16/17 animals) (Loy et al. 2012). This evidence 
demonstrates some form of long-lasting protection. In a WSSV challenge study, 
shrimp were vaccinated with VP28 and VP26dsRNA and the survivors were re-
challenged 3 times every 10 days post-initial infection with WSSV. The results 
showed 50% and 31% protection in VP28 and VP26dsRNA vaccinated groups, 
respectively (Mejía-Ruíz et al. 2011). Thus, these data may be the beginning of a 
paradigm shift in the understanding of the immune capacity of penaeid shrimp, i.e., 
shrimp have some form of memory immune response. This probably is not similar to 
memory mechanisms in vertebrates, with production of a clonal expansion of 
memory cells in to response to a specific pathogen infection. Further research is 
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needed to understand the underlying mechanisms of memory immune responses in 
invertebrates. The sequence-specific dsRNAs for WSSV and IMNV against viral 
diseases, which were generated in the studies described within this dissertation, 
could be used to interrogate the underlying mechanism of this long-term immunity. 
The development of an RNAi-based vaccine for use in the crustacean 
fisheries industry would offer several advantages. Firstly, the nature of dsRNA 
molecules is that they are more stable and resistant to nuclease degradation 
compared to single-stranded (antisense) RNA molecules that also can be antiviral 
when introduced into cells (Bertrand et al. 2002). Secondly, RNAi-based vaccines 
can be produced in a cost-effective manner. For example, a dsRNA-based product 
was developed to successfully to control Israeli Acute Paralysis virus (IAPV), one of 
the major causes of Colony Collapse Disorder (CCD) in the honeybee, Apis 
mellifera. The dsRNA product, Remebee-I has been applied to honey beehives by 
mixing with sugar water and feeding to honey bee colonies. The results showed that 
there was higher honeybee production in groups that were treated with Remebee-I. 
This was the first large-scale use of RNAi for disease control in insects (Hunter et al. 
2010). Cost-effective and the large-scale production of dsRNA have been developed 
using transformed RNase-deficient Escherichia coli (E. coli). Production in an E. coli 
based fermentation system reduces the cost reduction to one-fourth that of a 
commercial in vitro transcription kit (Saksmerprome et al. 2009). That said, the cost 
of production of an RNAi-based vaccine may be more expensive depending on the 
delivery system of choice. The dose of dsRNA and the frequency of application is 
another factor that will affect the cost production of RNAi-based vaccines (Leung & 
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Whittaker 2005). However, our data both in IMNV and WSSV infection showed that 
targeting an early event of infection can provide the highest efficacy (using small 
dose of dsRNA) to inhibit virus replication (Loy et al. 2013 and Chapter 4) , would 
greatly reduce the amount of dsRNA needed and thus the cost of production of a 
dsRNA vaccine. 
Oral vaccine delivery systems 
A delivery system that is compatible with organisms in an aquatic habitat is 
the ultimate goal and primary hurdle for implementation of an RNAi-based vaccine 
for crustacean fisheries. Delivery systems for human vaccines include virus vector 
systems such as alphaviruses, retroviruses, lentiviruses and adeno-associated 
viruses (AADV) and non-viral systems including, for example, lipid-based systems 
(Davidson & McCray 2011). In arthropods, RNAi technology is often implemented 
using injection because the specific dose and target site can be controlled; this 
method is impractical in field settings. In the case of the Remebee-I product, dsRNA 
is fed to the bees by mixing dsRNA with sugar water (Hunter et al. 2010). An RNAi-
based vaccine for aquatic animals presents an additional challenge in that the 
vaccine is potentially significantly diluted in water. The ideal vaccine for shrimp 
would be an oral application that is user-friendly for hatchery workers or farmers to 
apply. The development of an RNAi-based oral vaccine has shown some promising 
results; for example, nanoparticles made of chitosan mixed with dsRNAVP28 and 
top-coated onto feed. After feeding the treated feed to the shrimp, 37% survival was 
observed in WSSV-infected animals in comparison to the control group (Sarathi et 
al. 2008a). In the same study, inactivated DE3 E. coli expressing dsRNAVP28 was 
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top-coated onto feed and provided 68% protection compared to 0% in untreated 
animals. Another study showed successful incorporation of bacteria-expressed 
dsRNA targeting Laem-Singh Virus (LSNV). LSNV is associated with monodon slow 
growth virus syndrome (MSGS) in Black tiger shrimp (P. monodon). The results 
showed the mean body weight (MBW) of shrimp that received feed with dsRNA for 9 
weeks were higher and increased by 15% of biomass, which would account for 
$4800 more yield per pond (Saksmerprome et al. 2013b). These results are 
promising; however consistent technology for delivery of vaccines through feed 
should be developed to reduce the requisite dose, and improve the stability and 
efficacy of the antiviral effect in hatchery or pond settings.  
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Abstract 
Infectious myonecrosis virus (IMNV) causes significant economic losses in 
farmed shrimp, where associated mortality in ponds can reach 70%. To explore 
host-pathogen interactions, a next generation sequencing approach using lymphoid 
organ tissue from IMNV-infected shrimp, Litopenaeus vannamei, was conducted. 
Preliminary deep sequencing assembly showed that there were at least an 
additional 639 base pairs (bp) at the 5’ terminus and 23 bp at the 3’ terminus as 
compared to the original description of the genome (7561 bp). Reverse transcriptase 
PCR and Northern blot analysis confirmed the presence of novel sequence. Using 5’ 
Rapid Amplification of cDNA Ends (RACE), 4 additional nucleotides were 
discovered; 3’ RACE confirmed the presence of 22, rather than 23 bp of additional 
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sequence. Based on these data, the IMNV genome is 8226 bp in length1. Double-
stranded RNA was used to suppress expression of the newly revealed sequence at 
the 5’ end of the IMNV genome in IMNV-infected L. vannamei. Suppression of a 376 
bp region of the 5’UTR did not improve the survival rate of infected shrimp; in 
contrast, suppression of a 381 bp sequence that encompasses a portion of the 
coding region for ORF1 improved survival to 82.2% as compared to 2.2% survival in 
positive control animals. These studies reveal the critical nature of the new 
sequence to produce high titer infection, and associated disease and mortality, in 
infected shrimp. 
  
                                                
1 The GenBank accession number associated with this sequence is KF836757 
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Introduction 
A large number of pathogens threaten the shrimp aquaculture industry with a 
majority of these being viral in etiology. The total economic impact is significant, with 
losses in the billions of dollars (Lightner et al. 2012). The emergence of novel 
pathogens is inevitable because of the combined effects of high intensity farming, 
and a globalized aquaculture industry that exports and imports either live or 
unprocessed products and thereby rapidly disseminates pathogens worldwide. The 
emergence of Infectious myonecrosis virus (IMNV) is thought to have occurred via 
live animal movement from an endemic area to another intensive farming country 
(Senapin et al. 2007). Clinically, the gross signs of IMNV-infected animals are 
lethargy and the appearance of white muscle starting from the tail to abdominal 
muscle followed by mortality in ponds that can reach 70% (Senapin et al. 2007). 
IMNV was first reported in Brazil in 2003 after a disease outbreak occurred in 2002 
(Poulos et al. 2006) and this was followed by an outbreak in Indonesia in 2006 which 
caused devastating economic losses (Senapin et al. 2007).  
IMNV is non-segmented, doubled-stranded RNA virus with icosahedral 
symmetry and complex protrusions at the five-fold axis that are thought to be 
involved in virus entry (Tang et al. 2008). IMNV is classified in the family Totiviridae 
based on its genome organization and significant amino acid identity to Giardia 
Lamblia virus (GLV) in the RNA-dependent RNA polymerase (RdRp) coding region 
(Poulos et al. 2006). The IMNV genome encodes two open reading frames (ORFs). 
ORF 1 is translated into a polyprotein that contains a predicted dsRNA binding 
domain and a major capsid protein (MCP) while ORF 2 encodes the RdRp. Another 
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protein (a MCP-RdRp fusion product) is generated as a result of a -1 frameshift  
within ORF1 (Poulos et al. 2006, Nibert 2007). 
The IMNV genome was initially reported to be 7561 bp in length (Accession 
no. EF061744.2) (Senapin et al. 2007). Although the reported length of the IMNV 
genome was similar to that of other viruses in the family Totiviridae (5.0 - 7.0 kbp), 
the published IMNV sequence did not appear to have a predicted internal ribosomal 
entry site (IRES) in its 5’untranslated region (5’ UTR) that is characteristic of viruses 
in this family (Garlapati & Wang 2005). In addition, protein bands produced in 
purified IMNV protein preparations did not match the size of the proteins produced 
as a result of cleavage of the ORF1 polypeptide.  
To explore shrimp-virus interactions, we undertook a next generation 
sequencing (NGS) approach using lymphoid organ (LO) tissues from L. vannamei. 
The LO is located at the anterior end of the shrimp on the rostral-ventral side of 
hepatopancreas. One function of the LO is to remove pathogens from the 
hemolymph during circulation. Furthermore, the LO is a common site for virus 
replication and associated pathology (e.g., spheroids) to occur (Assavalapsakul et 
al. 2006, Escobedo-Bonilla et al. 2007). LO tissues express a significant amount of 
immune-related genes in normal and infected shrimp (Pongsomboon et al. 2008). It 
follows that significant transcriptional changes to this tissue would occur during 
active viral infection. We employed NGS to explore these transcriptional changes 
and to examine IMNV RNA production and breakdown during active IMNV infection. 
Surprisingly, we identified virus genome sequence that extends significantly beyond 
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the original description. This additional sequence encodes a genomic element that is 
key to virus replication.  
Materials and Methods 
Shrimp culture 
Specific Pathogen Free (SPF) L. vannamei were acquired from Shrimp 
Improvement Systems (Islamorada, FL, USA) and maintained in a specific pathogen 
free colony in a biosecure facility at Iowa State University. Post-larvae were placed 
into one ton fiberglass tanks filled with artificial sea water. Water conditions were 
maintained at 25-27 °C, 30-35 parts per thousand (ppt) salinity, with constant 
airstone aeration. Each tank was maintained with a carbon filter and an oyster shell 
airlift biofilter. Water quality was measured according to ammonia and nitrite levels 
(Nitriver3, Hach Company, Loveland, CO), and temperature and salinity were 
measured regularly. Shrimp were fed a commercial growout diet and cultured to 
different sizes for these studies. 
IMNV (Indonesia) infected-lymphoid organs 
The IMNV-infected tissues used for this study were collected during the IMNV 
outbreak in Indonesia. The virus inoculum was prepared as previously described 
(Loy et al. 2012). Six shrimp (15-20 grams in size) were infected by intramuscular 
injection with IMNV (strain Indonesia). Virus stock was prepared and diluted in 1:100 
2% NaCl (~2.11 x103 viral copy numbers µl -1 RNA) and filter-sterilized. Control 
shrimp were injected with 2% NaCl (viral diluent), as reported by Loy et al. 2012. 
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RNA sample and library preparation 
LO were collected from IMNV-infected animals at 5 days post-infection or 
from normal control shrimp at the same time. Gross organ characteristics were 
confirmed via light microscope on a dissecting microscope. All LO were preserved in 
RNAlater RNA Stabilization Reagent (Qiagen, Germantown, Maryland, USA) and 
stored at -80 °C. Samples were then transferred to 750 µl TRIzol LS (Invitrogen, 
Carlsbad, California, USA) and processed for RNA extraction. Residual DNA was 
removed from the extracted RNA using the TURBO DNA-freeTM kit (Ambion, Foster 
City, California, USA). RNA integrity was determination using an Agilent 2100 
bioanalyzer. Total RNA from 5-6 individual animals was pooled and diluted in 
nuclease free water to achieve a concentration of 0.1 µg ml-1. cDNA libraries were 
prepared from pooled RNA samples using the TruSeq RNA Sample Prep Kit 
(Illumina, San Diego, California, USA) following the manufacturer’s instructions. 
Illumina sequencing, sequence assembly and sequencing data processing 
cDNA libraries were subjected to 50 bp (single end) sequencing using the 
HiSeq2000 platform (Illumina). Raw sequencing reads were obtained and trimmed to 
remove adaptor sequences, empty reads, and low quality sequences using the 
FASTA-X toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). These reads were 
assembled using Velvet (1.2.08) (Zerbino & Birney 2008). The performance of 
Velvet assemblies is determined by hash length (k) and coverage cutoff (c). An 
iterative process was used to select the optimum k and c values to produce the best 
assembly (Liu et al. 2011). The parameters used for assembly of contigs were k=31 
and multiple c (c=2~10). To identify contigs derived from IMNV sequences, the 
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resulting contig sets (>=100nt) were aligned against IMNV genomic sequences by 
running the local Basic Local Alignment Search Tool (BLAST) (Altschul et al. 1990). 
To determine IMNV sequencing coverage, transcriptomic reads were clustered using 
the FASTA-X toolkit, and clustered reads were subsequently mapped to the IMNV 
genome using a custom-designed Perl program. The Perl script was designed to 
only permit mapping once to the reference sequence and n mismatched residues 
were allowed. The numbers of reads that mapped to each nucleotide position was 
used to calculate coverage (fold) of each nucleotide.  
A biological sequence alignment editor (BioEdit  v7.1.11) 
(http://www.mbio.ncsu.edu/bioedit/page2.html) was used as a platform for basic 
sequence manipulations of IMNV (sequence alignment, protein translation, ORF 
prediction, etc). ClustalW2 was used for multiple sequences alignment (Larkin et al. 
2007). 
Identification of sequences at the 5’ and 3’ends of the IMNV genome by 
reverse-transcriptase PCR 
Oligonucleotide primers were designed to amplify novel sequences at both 
the 5’ and 3’ ends of the IMNV genome (Table 1). Total RNA was extracted from 
shrimp inoculated with the Indonesia or Brazil strains of IMNV using TRIzol LS 
(Invitrogen). One-step reverse transcriptase PCR (one-step RT-PCR kit, Qiagen) 
was performed using the following amplification parameters: 50 °C for 30 min, 95 °C 
for 15 min and 35 cycles of 95 °C for 15 s, 55 °C for 30 s and 72 °C for 45 s, 
followed by a final elongation at 72 °C for 5 min. RT-PCR products were cloned into 
the pCR®2.1 vector (TOPO TA Cloning® kit, Invitrogen) and transformed into 
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competent E. coli cells (OneShot®TOP10, Invitrogen). Cells were grown on Luria-
Bertani agar containing kanamycin (50 µg/ml). A subset of colonies was screened 
for the presence of the desired insert by PCR, and these inserts were then purified 
and sequenced with vector-specific primers (M13F and M13R) using a 3730x1 DNA 
sequencer (Applied Biosystems, Foster City, California, USA) at the ISU DNA 
facility.  
Rapid Amplification cDNA Ends (RACE) PCR  
Reverse transcription 
Total RNA (1 µg) was mixed with 500µM of each dNTP and 25 µM of the 
appropriate reverse primer, heated at 70 °C for 10 min then chilled one ice for 1 min. 
Heat-denatured RNA was reversed transcribed at 50 °C for 50 min using 0.2 units of 
superscript III reverse transcriptase (Invitrogen) in 1x first strand buffer (50 mM Tris-
HCl [pH 8.3], 75 mM KCl, 0.6 mM MgCl2), 0.02 M dithiothreitol (DTT) then incubated 
at 70 °C for 15 min. The resulting cDNAs were purified using PCR purification kit 
(Purelink Quick PCR Purification Kit, Invitrogen).  
Polymerase Chain Reaction 
PCR amplifications were performed using 4 µl of cDNA, 1 unit of Platinum® 
Taq DNA Polymerase High Fidelity (Invitrogen), 20 µM of each primer, 0.2 mM of 
each dNTP and 2 mM MgSO4, in 1 x High Fidelity PCR Buffer (600 mM Tris-SO4 [pH 
8.9], 180 mM Ammonium Sulfate) using the following reaction conditions: 94 °C for 4 
min, 35 cycles of 94 °C for 30 s, 50 °C for 45 s and 72 °C for 90 s followed by a final 
extension at 72 °C for 8 min. PCR products were examined by 1% agarose gel 
electrophoresis.  
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5’ RACE PCR 
To identify the nucleotide sequences at the 5’ end of the IMNV genome, 5’ 
RACE was conducted. Total RNA was reverse transcribed using the appropriate 
primer (452R for IMNV [Indonesia] and 163R for IMNV [Brazil]), and the resulting 
cDNAs were purified using the Purelink Quick PCR Purification Kit (Invitrogen). 
Oligo(dC) tails were added to the 3’ end of 2 µg of purified cDNA using 15 units of 
terminal deoxynucleotidyl transferase (Invitrogen), 1mM dCTP and 50 µg/ml of 
bovine serum albumin in 1x tailing buffer (100 mM potassium cacodylate [pH 7.2], 2 
mM CoCl2, 0.2 mM DTT). Tailing reactions were performed at 37° C for 30 min and 
heat inactivated at 65 °C for 10 min. C-tailed products were purified then PCR 
amplified using a consensus forward primer specific to the C-tailed termini (C tail F) 
and one of several reverse primers specific to the IMNV cDNA sequences (428R for 
IMNV [Indonesia] and 243R for IMNV [Brazil]). The resulting products were cloned 
and transformed into competent E. coli cells. Selected colonies were screened by 
PCR using both vector-specific primers (M13F and M13R) and IMNV-specific 
primers (273F, 428R for IMNV [Indonesia] and 51F, 243R for IMNV [Brazil]). Select 
amplicons were purified (QIAquick PCR Purification Kit, Qiagen) and sequenced 
with an IMNV-specific reverse primer (374R for IMNV [Indonesia] and 304R for 
IMNV [Brazil]).  
3’ RACE PCR 
To identify the nucleotide sequences at the 3’ end of the IMNV genome, 
synthetic poly (A) tails were added to 10 µg of total RNA using 6 units of poly(A) 
polymerase A (Ambion) in 1 x reaction buffer (40 mM Tris-HCl, pH 8.0, 10 mM 
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MgCl2, 2.5 mM MnCl2, 250 mM NaCl, 50 µg of bovine serum albumin/mL, and 1 mM 
ATP). Tailing reactions were incubated at 37 °C for 1 hr and then placed in -20 °C 
for 2 min to inactivate the enzyme. Reaction products were purified by ethanol 
precipitation and poly (A)-tail enriched RNAs were reverse transcribed using a 
reverse primer specific to the poly(A) tail (3’ RT). Resulting cDNAs were then PCR 
amplified using the appropriate primers (IMNV7852F and 3’Rev). PCR products from 
the 3’ RACE were also cloned and screened with gene specific primers (IMNV7852F 
and 3’Rev) and plasmid primers (M13F and M13R) and then sequenced with 7945F 
for both IMNV strains. 
Doubled-stranded RNA synthesis 
Two dsRNAs, each approximately 381 bp in length, and corresponding to the 
newly identified IMNV genomic sequence were generated in the 639 bp of newly 
discovered sequence at the 5’ end. Primers for dsRNA synthesis were designed to 
amplify from position 26 to 312 nt (IMNV26T7F and IMNV401T7R) and 233 to 613 nt 
(IMNV233T7F and IMNV613T7R). The aforementioned dsRNAs are nearly identical 
in size to dsRNA95-475 (with the nt range dictated by position on the original IMNV 
genome sequence) which has proven protective effect in suppressing IMNV 
replication. dsRNA95-475 was generated according to the parameters described in a 
previous report (Loy et al. 2012). Briefly, a PCR was performed using primers that 
contained the T7 promoter sequence at the 5’ end (Table1). Complementary DNAs 
(cDNAs) were generated following the manufacturer’s instructions for ThermoScript 
TM RT (Invitrogen) using total RNA extracted from IMNV-infected shrimp and forward 
primer IMNV26F  (Table1). PCR was performed using PCR master mix (PuReTaq 
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Ready-To-Go PCR Beads, GE Healthcare, Pittsburgh, Pennsylvania, USA), cDNA 
template, and the primers containing T7 extensions (Table1) that were designed to 
specific regions of the newly revealed IMNV genome sequence. The reaction 
conditions were 95 °C for 4 min, followed by 35 cycles of 95 °C for 30 s, 55 °C for 30 
s, 72 °C for 45 s and then a final elongation of 72 °C for 7 min. The resulting PCR 
products were confirmed to have a molecular weight approximately 381 bp by 
agarose gel electrophoresis. Nucleotides, enzymes and buffer were removed using 
the QIAquick PCR purification kit (Qiagen). PCR products were concentrated by 
vacuum concentrator (DNA120 SpeedVac, Thermo Scientific, Waltham, 
Massachusetts) and 1 µg of purified PCR product was added to an in vitro 
transcription reaction. The synthesis reaction was incubated at 37 °C for 12-16 
hours. The dsRNA synthesis product was then incubated for 45 min in a buffer 
solution containing RNase and DNase I. Following incubation, dsRNA was purified 
using the provided purification columns. The formation of dsRNA was confirmed by 
1% agarose gel electrophoresis, and quantified by spectrophotometry (Nano 
Drop2000, Thermo Scientific). The dsRNAs were stored in -20 °C until use and were 
then diluted in RNase free water to reach the desired concentration. 
IMNV (Brazil) viral isolation 
IMNV (Brazil) was kindly provided by the Aquaculture Pathology laboratory at 
the University of Arizona. Virus inoculum was clarified directly from frozen infected 
samples as previously described (Loy et al. 2012). Shrimp (7-10 gram) were injected 
intramuscularly (100 µL) with 1:100 dilution of IMNV (Brazil) (~7.2 x102 viral copy 
numbers µl -1 RNA) (Loy et al. 2012). Clinical signs of lethargy and white muscle 
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were observed at 3 days post-infection. Moribund shrimp with gross lesions were 
collected for RNA extraction using the Qiagen RNeasy Minikit according to the 
manufacturer’s instructions. RNA from shrimp infected with IMNV (Brazil) was tested 
by RT-PCR and molecular weight was confirmed on a 1% agarose gel stained with 
ethidium bromide. 
Determination of novel dsRNA efficacy in vivo 
Shrimp (3-5 gram) were divided into 5 groups of 10 shrimp with 3 replicates in 
each group (total 30 shrimp/group) and 10 shrimp for negative control. Tanks were 
maintained at 29-30 °C. Shrimp were injected intramuscularly with 5 µg/shrimp (100 
µl) of dsRNA95-475, dsRNA26, dsRNA233 and dseGFP or 2% NaCl, and at 48 
hours post-injection (p.i.) with 2% NaCl (negative control group) or IMNV 1:100 
dilution of IMNV (Indonesia) that reach 95-100% mortality within two weeks (~2.11 
x103 viral copy numbers µl -1 RNA) (Loy et al. 2012). Shrimp were fed and mortality 
observed twice per day. These studies were in triplicate. Tissue samples from 
moribund and dead shrimp were stored at -80 °C for further quantification of virus 
copy number.  
Quantitative Reverse-Transcription PCR 
A qRT-PCR assay for virus load was adapted from a previously described 
method (Andrade et al. 2007). RNA was extracted using the RNeasy Minikit 
(Qiagen) and 3 µl of sample was added to each reaction of One Step RT-PCR 
Master Mix (Qiagen). The one step RT-PCR reaction mix contained 5 x Master Mix 
(5 µl), Enzyme mix (1 µl), 10 mM dNTP (1 µl), 20 µM of IMNV412F (0.3 µl), 20 µM 
IMNV545R (0.3 µl) and 10 µM IMNV probe (0.3 µl) and RNase-free water (14.1 µl) 
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for a total volume of 25 µl. The qRT-PCR was performed with conditions from a 
previous report (Loy et al. 2012). Each reaction was run in duplicate on a BioRad 
CFX96 Real Time PCR Detection System using a standard as described previously 
(Andrade et al. 2007, Loy et al. 2012).  
IMNV purification 
  IMNV was purified using a combination of methods adapted from Mello et al. 
(2011) and Poulos et al. (2006). Briefly, one hundred 7-10 gram shrimp were 
infected with 1:100 dilution of IMNV (Indonesia) (Loy et al. 2012). Moribund shrimp 
were collected during a 2 week course of infection to obtain approximately 500 g of 
IMNV tissue from acutely infected animals. Heads were removed to reduce the 
amount of lipid input into the virus purification process. Infected tissues were placed 
in 0.1 M PBS buffer, pH 7.5 plus 0.5% of Na2SO (w/v) at a ratio of 1:3 and 
homogenized in a blender. Additionally, 10% chloroform (v/v) was added into the 
homogenate and was then centrifuged at 8000 × g for 15 min to clarify the 
suspension. Following the first centrifugation, the supernatant was removed and 
centrifuged again to remove tissue debris. The supernatant was collected and 
precipitated by adding 10% polyethylene glycol (w/v) and 4% NaCl (w/v), stirred at 
4 °C for 1 h, and centrifuged at 8000 × g, at 4 °C for 20 min (Mello et al. 2011). The 
pellet was then resuspended and loaded onto a 10-40% sucrose gradient and 
centrifuged at 70,000 × g for 2 h at 4 °C. A pellet was observed in the bottom of 
ultracentrifuge tube at the 40% sucrose gradient. The virus pellet was removed from 
the ultracentrifuge tube and diluted in the same buffer to be stored at -80°C. The 
presence of virus in the pellet was confirmed by RNA extraction and RT-PCR. 
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Purified virus was also injected intramuscularly into 7-10 gram shrimp to confirm the 
presence and viability of virus in the preparation.  
Northern blot analysis 
Northern blot analysis was performed using methods adapted from Current 
Protocols in Molecular Biology (Brown et al. 2001). Briefly, total RNA was extracted 
from purified IMNV using Trizol LS (Invitrogen) and 5 µg was resolved on a 1% 
agarose glyoxal gel (NorthernMax-Gly, Life technologies). The gel was observed for 
presence of RNA via ethidium bromide staining in a UV light box prior to transfer. 
Then RNA was nicked with 500 kilojoules UV light and transferred to a positively 
charged membrane (Whatman® Nytran™ Supercharge TurboBlotter, Sigma Aldrich) 
using a passive downhill transfer technique for 1 hour. Membranes were UV cross-
linked at 1200 kilojoules and hybridized overnight ULTRAhyb® Ultrasensitive 
Hybridization Buffer (Ambion) at 68 °C with Biotinylated RNA probes. Biotinylated 
RNA probes were generated using BrightStar® Psoralen-Biotin Nonisotopic Labeling 
Kit (Ambion) that were designed target to the original sequence of IMNV including 95 
sense and 475 antisense probes and to the novel sequences at the 233 sense and 
613 antisense probes (Table 1). PCR templates with T7 sequence at the 5’-ends 
were used to generate RNA in vitro transcripts (T7 RNA polymerase, Promega). 
RNA transcripts were then labeled with biotin according to the manufacturer’s 
instruction to create biotinylated probes (BrightStar Biotin-Psoralen Kit). The 
hybridized membranes were developed following the manufacturer’s instruction and 
the signal was detected by chemiluminescence using the BrightStar BioDetect Kit 
(Ambion). 
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Statistical analysis 
Survival and qRT-PCR data were analyzed using one-way ANOVA followed 
by Tukey’s multiple comparison test (p<0.05) using JMP pro 10 software (SAS 
Institute Inc.).  The survival data and viral copy number were expressed as the mean 
± standard error (SEM). Mean survival data were tested at the termination of 
experiment on day 14 post-infection and the mean log viral copy number was 
compared between groups. 
Results and Discussion 
IMNV sequencing analysis 
A total of 43,567,120 trimmed reads of 50 bp were obtained from IMNV-
infected shrimp and used for the sequence assembly. To identify IMNV sequence, 
each of the contig sets was aligned to the existing IMNV sequence (Accession No. 
EF061744.1). Two IMNV contigs were identified, one that is 8044 bp in length and 
another one that is 8223 bp. Both contig8044 and contig8223 are significantly longer 
in size than that of the published IMNV genomic sequence (7561 bp). A sequence 
alignment revealed that the 663 bp of new, putative IMNV sequence is not within the 
limits of the known sequence but falls primarily upstream of the 5’end (639 bp) and, 
to a more limited extent, at the 3’end (23 bp) as shown in Fig. 1.  
The new 5’-end and the known IMNV sequences have an equal depth of 
sequencing 
IMNV sequences subjected to de novo assembly revealed possible novel 
sequences in the IMNV genome. To determine whether the new sequence 
fragments were represented with the same coverage as the published sequence, we 
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mapped the RNA-seq reads across the length of the genome (Fig. 2). Sequence 
coverage of the new sequences and the documented sequence are listed in Table 2. 
Although there were significant variations of the sequencing depth at specific 
nucleotide locations in the IMNV genome, the average sequencing coverage 
between the new and known sequences was similar (Table 2), suggesting that the 
new sequences were equally represented in the cDNA library.  
Confirmation of presence of sequence in IMNV Indonesia and Brazil 
Deep sequencing results indicate that there are at least an additional 639 bp 
at the 5’-end and 23 bp at 3’-end when compared to the published IMNV genomic 
sequence. Several sets of primers were designed to confirm the presence of these 
novel IMNV sequences in Indonesia and Brazil isolates. Four sets of primers were 
used to confirm the presence of additional sequence at the 5’-end by RT-PCR 
including IMNV26F, IMNV312F, IMNV643R and IMNV1016R (Table 1). Previously 
published primers (95F, 475R) that amplify the known genome sequence were used 
as positive controls (Table 1). RT-PCR amplicons were subjected to gel 
electrophoresis and molecular weights were confirmed as predicted (Fig. 3, lane 1-
4). The largest amplicon (990 bp, lane 4, Fig. 3.) was cloned and sequenced and 
had 95% nucleotide identity compared to the published IMNV sequence in Genbank. 
These four new primer pairs also were tested with IMNV (Brazil). RT-PCR results 
were identical to those for IMNV (Indonesia) (Fig. 3, lane 5-8) and sequenced PCR 
products had 100% and 99% identity to IMNV (Brazil) and IMNV (Indonesia), 
respectively. 
Two reverse primers (IMNV8204R1, IMNV8204R2) were designed to confirm 
the present of additional sequence at the 3’ end of the IMNV genome (Table1). 
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Reverse primers successfully amplified the novel sequences in both IMNV strains 
(Fig. 4), confirming that these extra sequences at 3’ end are present, as revealed in 
the deep sequencing data.  
IMNV genome sized determination and Northern blot analysis   
Gel electrophoresis was used to further confirm the size of the IMNV genome 
based on comparison to molecular weight markers. A distinct band of 8 kb was 
evident (Fig. 5). Total RNA from purified IMNV and non-infected shrimp were 
subjected to Northern analysis with RNA probes generated to the original sequences 
and novel sequences. A band of approximately 8-9 kb representing the IMNV 
genome was evident in IMNV RNA regardless of the RNA probes used, but not in 
uninfected animals (Fig. 6). These results further confirm that the novel sequence 
discovered by deep sequencing exists in the IMNV genome. 
Analysis of the newly identified sequences at the 5’-end of the IMNV genome 
   The published IMNV sequence encodes two predicted ORFs. To clarify 
whether 639 bp of the new 5’- end sequences encodes any proteins, we translated 
sequence of Contig8223 in all six frames (Fig. 7). The translation results show that, 
like the published IMNV sequence, the new IMNV genome also encodes two ORFs. 
The ORF2 (frame 3) is almost identical to the documented ORF2 sequences. 
However, the predicted ORF1 (frame one) in Contg8223 is comprised of 1719 aa, 
which is 114 aa larger than the documented ORF1 (1605 aa). The predicted start 
codon of the new ORF1 is at 342 bp upstream of the documented start codon. Fig. 8 
shows the new N-terminal sequence and its alignment with the published IMNV 
ORF1 sequence.  
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Examination of IMNV ORF sequence has revealed that the ORF1 contains 2 
“2A-like” peptide cleavage motifs (Nibert 2007), and  another cleavage site that 
cleaves the C-terminus of ORF1 to release the MCP. These three cleavage motifs 
hydrolyze the ORF1 polyprotein into 4 products: the N-terminal peptide 1 (10 kDa), 
peptide 2 (31 kDa), predicted peptide 3 (36 kD) and the C-terminal 99 kDa MCP. 
The ORF2 (frame 3) is translated by -1 ribosomal frame shifting within ORF1, and 
produces a 196 kDa MCP-RdRp fusion product (Poulos et al. 2006, Nibert 2007, 
Tang et al. 2008). Hence, 5 peptide fragments should be expected. Our new N 
terminal sequence extends peptide 1 to a predicted 207 residue (23 kDa) protein. 
Tang et al. showed that when purified IMNV virions were separated by SDS-PAGE 
and stained, 5 distinct protein bands could be observed. The 99 kDa and 196 kDa 
bands correspond to MCP and MCP/RdRp, respectively. The remaining 3 bands 
were between 25 kDa and 40 kDa (Tang et al. 2008). Therefore, it is likely that the 
25 kD protein that was observed is peptide 1 and the other two bands are peptides 2 
and 3.  
5’ and 3’ RACE PCR confirm the presence of novel sequences in the IMNV 
genome 
To confirm the presence of the IMNV sequences identified by NGS, 5’ and 3’ 
RACE were performed. Fourteen PCR products generated from the 5’ RACE of 
IMNV (Indonesia) were sequenced and confirmed the presence of 639 bp identified 
by NGS, and revealed an additional 4 bp upstream. The additional 4 bp were 
present both in IMNV (Indonesia) and IMNV (Brazil). Thus, 5’ RACE PCR confirmed 
that the IMNV sequences previously published and available in Genbank 
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(NC_007915.2, AY570982.2, EF061744.1; 7561 bp) are truncated at the 5’ terminus 
by 643 bp.  
Because the IMNV genome is not polyadenylated, a synthetic poly (A) tail 
was added to the 3’ end and then 3’ RACE experiments were performed to confirm 
the presence of additional sequence at the 3’ terminus of the genome. Ten PCR 
products were generated and sequenced using 3’ RACE on IMNV (Brazil). These 
experiments confirmed that an additional 22 bp are present at the distal 3’ end 
supporting the findings from the NGS analysis. We were unable to generate any 
positive clones by 3’ RACE with IMNV (Indonesia). However, we were able to 
amplify and sequence the 3’ end of IMNV (Indonesia) using (IMNV7852F) as the 
forward primer and (IMNV8210R2) as the reverse primer; the sequence of the latter 
primer corresponds to the distal 22 bp of the 3’ UTR of IMNV (Brazil) (Table1). 
These data indicate that an additional 22 bp is present at the 3’ end of the genome 
of both virus strains. Therefore, using 5’ and 3’ RACE, we confirmed the presence of 
the nucleotide sequences identified by NGS at the 5’ and 3’ ends of the IMNV 
genome, and revealed the presence of another 4 bp at the distal 5’ end as shown in 
Fig. 9. The full-length 8226 bp genomic sequence of IMNV (Indonesia) was 
submitted to Genbank (Accession No. KF836757).  
Novel IMNV dsRNA showed protection against IMNV 
In order to test the biological function of the novel sequences at the 5’ 
terminus of IMNV, two dsRNAs (designated dsRNA26 and dsRNA233) were 
designed and compared to dsRNA95-475, which targets the coding region of peptide 
1. dsRNA95-475 was previously shown to provide 81.7% survival in animals infected 
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with IMNV at 30 days post-infection (Loy et al. 2012). Therefore, dsRNAs to the 
novel sequence were designed to have similar length to dsRNA95-475. Each shrimp 
was injected with 5 µg (100 µl) of either dsRNA26, dsRNA233, dsRNA95-475, 
dsRNAeGFP or 2% NaCl (sham-inoculation), held for 48 hours and then inoculated 
with IMNV (1:100). Negative control shrimp were also injected with 2% NaCl (virus 
diluent). In three separate trials, significant mortality was observed in shrimp 
exposed to dsRNA26, dsRNAeGFP or no with 3.3%, 2.2% and 2.2% mean survival, 
respectively. In contrast, shrimp that received dsRNA233 and dsRNA95-475 showed 
similar protection against IMNV with mean survival of 82.2% and 97.8%, respectively 
at 14 days post-infection as shown in Fig. 10. Mean survivals are significantly 
different from other groups (dsRNAeGFP, dsRNA26 and positive control) (p<0.001) 
using one-way ANOVA followed by Tukey’s multiple comparison test (JMP pro 10 
software, SAS Institute Inc.). All negative control animals (non-challenged) survived 
during the full course of these experiments. Therefore, only dsRNA233, which 
encompasses ORF1 as compared to dsRNA26 which encompasses 5’ UTR 
sequence, showed protection against IMNV but the protection efficacy is similar to 
dsRNA95-475. 
Novel IMNV dsRNA inhibition of IMNV replication 
Viral load as measured by copy number was analyzed by qRT-PCR on 
muscle tissues from dead and survived animals in dsRNA26, dsRNAeGFP and 
positive control groups at 9-14 days post-infection and the dsRNA233 and 
dsRNA95-475 groups at 14 days post-infection. The results showed that dsRNA95-
475 and dsRNA233 can inhibit virus replication (mean 4.5 x 102 and 2.9 x 103 IMNV 
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copy numbers µl-1 RNA, respectively) and are significantly different from the positive 
control group (mean 1.1 x 105 IMNV copy numbers µl-1 RNA) (p= 0.013 and 0.016, 
respectively). By contrast, dsRNA26 and dsRNAeGFP-exposed shrimp did not show 
reduction of virus (mean 4.8 x 104 and 7.7 x 104 IMNV copy numbers µl-1 RNA, 
respectively) (Fig. 11). This is further evidence that dsRNA233 suppresses virus 
replication during IMNV infection.  
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A) 
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       TCTACATCTGGCCAAGGAAAATCTGTTCGTAGGCAAGAACGAAGTGGCTATGGGGTTTGA 60 
Contig8044       TCTACATCTGGCCAAGGAAAATCTGTTCGTAGGCAAGAACGAAGTGGCTATGGGGTTTGA 60 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       GGTTTAGCCGAAAGAGATCTCGACAGTCTTTAGTAGGATACACTTCTTACACTCCTGGGA 120 
Contig8044       GGTTTAGCCGAAAGAGATCTCGACAGTCTTTAGTAGGATACACTTCTTACACTCCTGGGA 120 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       AAGAGAAACATTATCTGTCCAGCAATGATACACGGGTACGTCCTCCATTAGCTGTTGTTT 180 
Contig8044       AAGAGAAACATTATCTGTCCAGCAATGATACACGGGTACGTCCTCCATTAGCTGTTGTTT 180 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       TCTTTTCCTCGGCAGGTCCTACAATGTCGGAGCGCAGGAACAGGACGAACCCACGAGTCG 240 
Contig8044       TCTTTTCCTCGGCAGGTCCTACAATGTCGGAGCGCAGGAACAGGACGAACCCACGAGTCG 240 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       CATCCTTACGAGAAGTGCAGTAGGTTGGCGCTGTTGAGAGCGGGTGATCTGGGTAATGTC 300 
Contig8044       CATCCTTACGAGAAGTGCAGTAGGTTGGCGCTGTTGAGAGCGGGTGATCTGGGTAATGTC 300 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       CGTCGTTACGGGTAGCATTACTTGGCGCATGCAGTGGGAAGTCATGGCCCACGTCACCTT 360 
Contig8044       CGTCGTTACGGGTAGCATTACTTGGCGCATGCAGTGGGAAGTCATGGCCCACGTCACCTT 360 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       AACAAAAGACTAGTCCGACTGTAACCTCGGCGTATAGCGAAAGCGGTTAGATAACATTAA 420 
Contig8044       AACAAAAGACTAGTCCGACTGTAACCTCGGCGTATAGCGAAAGCGGTTAGATAACATTAA 420 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       ATACCGGCTTGTATGCTAGAAACTGGACTGTCCATATACCATTGGATGTCTCAAACAAAG 480 
Contig8044       ATACCGGCTTGTATGCTAGAAACTGGACTGTCCATATACCATTGGATGTCTCAAACAAAG 480 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       AATAAAGAACCTGTTGTTGAACAGCAAAATCAACAAACCTTCAACCAAAAAGACCACAAT 540 
Contig8044       AATAAAGAACCTGTTGTTGAACAGCAAAATCAACAAACCTTCAACCAAAAAGACCACAAT 540 
                                                                              
 
NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
Contig8223       GCGCTAGTGATTGAACACAAAACTAGTGCAACAACGAGCGCCCAAAGCATTCCCGTTCGT 600 
Contig8044       GCGCTAGTGATTGAACACAAAACTAGTGCAACAACGAGCGCCCAAAGCATTCCCGTTCGT 600                                                                       
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NC_007915.1      ---------------------------------------GGCAATTTCAACCTAATTCTA 21 
AY570982.1       ---------------------------------------GGCAATTTCAACCTAATTCTA 21 
EF061744.1       ---------------------------------------GGCAATTTCAACCTAATTCTA 21 
Contig8223       CCTTCACGTAAGAAGGATGACTATGTGGACATGACACAGGGCAATTTCAACCTAATTCTA 660 
Contig8044       CCTTCACGTAAGAAGGATGACTATGTGGACATGACACAGGGCAATTTCAACCTAATTCTA 660 
                                                        ********************* 
 
 
B) 
	  
NC_007915.1      ATAAGATCGCCAAATTTATTTACCAAAAA-CAAAACAAGCAGAGAACATGATACTGCAAA 7460 
AY570982.1       ATAAGATCGCCAAATTTATTTACCAAAAA-CAAAACAAGCAGAGAACATGATACTGCAAA 7460 
EF061744.1       ATAAGATCGCCAAATTTATTTACCAAAAAACAAAACAAGCAGAGAACATGATACTGCAAA 7461 
Contig8223       ATAAGATCGCCAAATTTATTTACCAAAAAACAAAACAAGCAGAGAACATGATACTGCAAA 8100 
Contig8044       ATAA-------------------------------------------------------- 8044 
                 ****                                                         
 
NC_007915.1      GTAGTTTACAACAAATGTATAGGTACTAAATTAAGGGACCAATAAAGAAACTTCGAGTTT 7520 
AY570982.1       GTAGTTTACAACAAATGTATAGGTACTAAATTAAGGGACCAATAAAGAAACTTCGAGTTT 7520 
EF061744.1       GTAGTTTACAACAAATGTATAGGTACTAAATTAAGGGACCAATAAAGAAACTTCGAGTTT 7521 
Contig8223       GTAGTTTACAACAAATGTATAGGTACTAAATTAAGGGACCAATAAAGAAACTTCGAGTTT 8160 
Contig8044       ------------------------------------------------------------ 
                                                                              
 
NC_007915.1      CCTATAACACATTCCCAGTTGGGTTTTGTGGCCAGCCATG-------------------- 7560 
AY570982.1       CCTATAACACATTCCCAGTTGGGTTTTGTGGCCAGCCATG-------------------- 7560 
EF061744.1       CCTATAACACATTCCCAGTTGGGTTTTGTGGCCAGCCATG-------------------- 7561 
Contig8223       CCTATAACACATTCCCAGTTGGGTTTTGTGGCCAGCCATGCGGTTGGCCCTAGGTTATAG 8220 
Contig8044       ------------------------------------------------------------ 
                                                                              
 
NC_007915.1      --- 
AY570982.1       --- 
EF061744.1       --- 
Contig8223       TCG 8223 
Contig8044       --- 
 
Fig. 1. Sequence alignment (partial) of Contig8044, Contig8223 and the published 
IMNV sequences. The alignment was generated by ClustalW2 algorithm. A) 5’- end 
alignment of the sequences shows sequence differences between the contig8044, 
contig8023 and the published sequences (NC_007915.2, AY570982.2 and 
EF061744.1). B) The 3’-end alignment of the contigs and IMNV sequences.  
*Strictly conserved nucleotide sequences. 
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Fig. 2. Sequencing coverage of IMNV genomic sequences. The Illumina reads used 
for assembling the IMNV contigs (8223 bp) were mapped to the assembled IMNV 
sequence using a customer designed Perl program. No mismatched bases were 
allowed in the algorithm. The sequencing coverage was calculated by converting the 
numbers of mapped reads in the corresponding positions of the IMNV sequences to 
numbers of times that mapped to each base. Reads of the plus strand (blue) and 
minus strand (red) were calculated separately.  
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Fig. 3. RT-PCRs performed using four different pairs of primers specific to the 5’-end 
of the Indonesia (lanes 1-4) and Brazil (lanes 5-8) strains of IMNV confirmed the 
presence of the novel sequences. Primers specific to previously recognized IMNV 
sequence were included as positive controls (lane 9). M=Molecular weight marker. 
These four new primers were also tested on RNA from specific free pathogen (SPF) 
shrimp and the RT-PCR results were negative for all new primers at a variety of 
cycling conditions (data not shown). 
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Fig. 4. RT-PCRs performed using two different pairs of primers specific to the 3’-end 
of the Indonesia (lanes 1-2) and Brazil (lanes 3-4) strains of IMNV confirmed the 
presence of the novel sequence. These primers were tested with SPF shrimp and 
showed no amplification of cDNA, indicating that sequences are present only in 
virus-infected tissues (data not shown). 
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Fig. 5. SPF Virus Negative shrimp RNA (lane 3) and IMNV viral RNA purified from 
shrimp tissues (lane 2) (2 µg) were subjected to electrophoresis on a denaturing 
0.8% agarose glyoxal gel containing ethidium bromide. Two markers have been 
used to determine the molecular weight of RNA products, and IMNV genome 
including 0.5-9 kb Millennium Markers (Ambion) (lane 1) and 0.5-10 kb RNA ladder 
(Invitrogen) (lane 4). 
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Fig. 6. RNA subjected to electrophoresis on a denaturing 1% agarose glyoxal gel 
that was loaded with 5 µg total RNA extracted from negative shrimp tissues to 
ensure probe specificity to virus RNA (U= uninfected tissue) and extracted from 
clarified IMNV infected shrimp tissues (I= infected tissue). The gel was then 
passively transferred to positively charged membrane (Sigma Aldrich) and 
hybridized overnight at 68 °C with different virus specific biotinlyated RNA probes 
generated that correspond to original sequences including 95F, 475R, and novel 
sequences including 275F and 613R. F indicates sense probe and R indicates 
antisense probe. The bars indicate the pairs of RNA gels and positively charged 
membranes. M is 0.5-9 kb Millennium Markers (Ambion). 
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1     TCT ACA TCT GGC CAA GGA AAA TCT GTT CGT AGG CAA GAA CGA AGT   45 
1      S   T   S   G   Q   G   K   S   V   R   R   Q   E   R   S    15 
 
46    GGC TAT GGG GTT TGA GGT TTA GCC GAA AGA GAT CTC GAC AGT CTT   90 
16     G   Y   G   V   *   G   L   A   E   R   D   L   D   S   L    30 
 
91    TAG TAG GAT ACA CTT CTT ACA CTC CTG GGA AAG AGA AAC ATT ATC   135 
31     *   *   D   T   L   L   T   L   L   G   K   R   N   I   I    45 
 
136   TGT CCA GCA ATG ATA CAC GGG TAC GTC CTC CAT TAG CTG TTG TTT   180 
46     C   P   A   M   I   H   G   Y   V   L   H   *   L   L   F    60 
 
181   TCT TTT CCT CGG CAG GTC CTA CAA TGT CGG AGC GCA GGA ACA GGA   225 
61     S   F   P   R   Q   V   L   Q   C   R   S   A   G   T   G    75 
 
226   CGA ACC CAC GAG TCG CAT CCT TAC GAG AAG TGC AGT AGG TTG GCG   270 
76     R   T   H   E   S   H   P   Y   E   K   C   S   R   L   A    90 
 
271   CTG TTG AGA GCG GGT GAT CTG GGT AAT GTC CGT CGT TAC GGG TAG   315 
91     L   L   R   A   G   D   L   G   N   V   R   R   Y   G   *    105 
 
316   CAT TAC TTG GCG CAT GCA GTG GGA AGT CAT GGC CCA CGT CAC CTT   360 
106    H   Y   L   A   H   A   V   G   S   H   G   P   R   H   L    120 
 
361   AAC AAA AGA CTA GTC CGA CTG TAA CCT CGG CGT ATA GCG AAA GCG   405 
121    N   K   R   L   V   R   L   *   P   R   R   I   A   K   A    135 
 
406   GTT AGA TAA CAT TAA ATA CCG GCT TGT ATG CTA GAA ACT GGA CTG   450 
136    V   R   *   H   *   I   P   A   C   M   L   E   T   G   L    150 
 
451   TCC ATA TAC CAT TGG ATG TCT CAA ACA AAG AAT AAA GAA CCT GTT   495 
151    S   I   Y   H   W   M   S   Q   T   K   N   K   E   P   V    165 
 
496   GTT GAA CAG CAA AAT CAA CAA ACC TTC AAC CAA AAA GAC CAC AAT   540 
166    V   E   Q   Q   N   Q   Q   T   F   N   Q   K   D   H   N    180 
 
541   GCG CTA GTG ATT GAA CAC AAA ACT AGT GCA ACA ACG AGC GCC CAA   585 
181    A   L   V   I   E   H   K   T   S   A   T   T   S   A   Q    195 
 
586   AGC ATT CCC GTT CGT CCT TCA CGT AAG AAG GAT GAC TAT GTG GAC   630 
196    S   I   P   V   R   P   S   R   K   K   D   D   Y   V   D    210 
 
631   ATG ACA CAG GGC AAT TTC AAC CTA ATT CTA AAA CTG TTA CCA ACA   675 
211    M   T   Q   G   N   F   N   L   I   L   K   L   L   P   T    225 
 
676   ATT TCT GAA CTA CAG AAG AGG CAT ATT CTT CAT CTA CTT CGA GAA   720 
226    I   S   E   L   Q   K   R   H   I   L   H   L   L   R   E    240 
 
721   GAA GTA GAA GGA AAG AAA GTT TGT TTC GTA AAG CGA GAA AAA CAG   765 
241    E   V   E   G   K   K   V   C   F   V   K   R   E   K   Q    255 
 
766   AAT CCA CTT ATG GCT ATA AAC GAA CTA GCC GTT AAA GTT GGA GAG   810 
256    N   P   L   M   A   I   N   E   L   A   V   K   V   G   E    270 
 
811   AAG CCT AAA TAC ACA TCG ACG AAA ACC GGA GCT GAC CAC ATT CCA   855 
271    K   P   K   Y   T   S   T   K   T   G   A   D   H   I   P    285 
 
856   AGC TGG ACT GTA TTG GTT GAG TTC GCA GGT TTT AGC GAA GCA GCG   900 
286    S   W   T   V   L   V   E   F   A   G   F   S   E   A   A    300 
 
901   ACA TGT GAC ACA GTT AAA AAC GCA AAA ATG ATT GCT GCT TAC AAA   945 
301    T   C   D   T   V   K   N   A   K   M   I   A   A   Y   K    315 
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946   TTA GTT AAA AGA TTT TGT AAA TGG GAC CCA ACC TAC ATT GAA ATT   990 
316    L   V   K   R   F   C   K   W   D   P   T   Y   I   E   I    330 
 
991   TCT GAT TGT ATG CTG CCA CCT CCA GAC CTT ACA TCG TGC GGG GAC   1035 
331    S   D   C   M   L   P   P   P   D   L   T   S   C   G   D    345 
 
1036  GTT GAG AGT AAT CCT GGA CCT ATC ATA CAT AGC GTT GCA TTT GCA   1080 
346    V   E   S   N   P   G   P   I   I   H   S   V   A   F   A    360 
 
1081  AGA ACT GGT TCA GTA TGG ACA CCT GCC ACC TTT ACT TTC AAT ACT   1125 
361    R   T   G   S   V   W   T   P   A   T   F   T   F   N   T    375 
 
1126  ACA TCA TCC CCG GGT AGA CTG CAA GTA CAA ATG TCA TCC AGC GAC   1170 
376    T   S   S   P   G   R   L   Q   V   Q   M   S   S   S   D    390 
 
 
Fig. 7. Translation of the new 5’- sequences of IMNV.  The new IMNV sequences 
were translated (six frames) using BioEdit program. The figure shows the 5’-end of 
the frame 1 translation. The first start codon (ATG) in frame one (italic M) locates at 
433 bp, which starts a peptide sequences and merge the peptide sequence into the 
known ORF1 sequence started at 775 bp (bold M) of the new IMNV sequence.  
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NC_007915.1      ------------------------------------------------------------ 
AY570982.1       ------------------------------------------------------------ 
EF061744.1       ------------------------------------------------------------ 
New_ORF1         MLETGLSIYHWMSQTKNKEPVVEQQNQQTFNQKDHNALVIEHKTSATTSAQSIPVRPSRK 60 
                                                                              
 
NC_007915.1      ------------------------------------------------------MAINEL 6 
AY570982.1       ------------------------------------------------------MAINEL 6 
EF061744.1       ------------------------------------------------------MAINEL 6 
New_ORF1         KDDYVDMTQGNFNLILKLLPTISELQKRHILHLLREEVEGKKVCFVKREKQNPLMAINEL 120 
Consensus                                                              ****** 
 
NC_007915.1      AVKVGKKPKYTSTKTGADHIPSWTVLVEFAGFSEAATCDTVKNAKMIAAYKLVKRFCKWD 66 
AY570982.1       AVKVGKKPKYTSTKTGADHIPSWTVLVEFAGFSEAATCDTVKNAKMIAAYKLVKRFCKWD 66 
EF061744.1       AVKVGKKPKYTSTKTGADHIPSWTVLVEFAGFSEAATCDTVKNAKMIAAYKLVKRFCKWD 66 
New_ORF1         AVKVGEKPKYTSTKTGADHIPSWTVLVEFAGFSEAATCDTVKNAKMIAAYKLVKRFCKWD 180 
Consensus        *****:****************************************************** 
 
 
Fig. 8. Alignment of the new ORF1 and the published ORF1 protein sequences 
(partial, N-terminus). The multiple amino acid sequence alignments show that the 
new ORF1 has additional 114 residues at the N-terminus compared to the published 
ORF1 sequences.  
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Fig. 9. Genomic organization of IMNV (Indonesia). Previously published information 
indicates a genome length of 7561 bp (Accession No. AY570982.1, top). Newly 
revealed sequence information indicates the virus genome length is 8226 
bp (Accession No. KF836757, bottom). The predicted putative ORF1 contains 1719 
aa and thus is 114 aa longer than the previously reported sequences (1605 
aa).  Nucleotide positions indicate the following genome features; A is 5’UTR, B is 
ORF1, C is intergenic region, D is ORF2 and E is 3’UTR.  
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Fig.10. Shrimp survival post-administration with novel dsRNAs (dsRNA26 and 
dsRNA233) compared with previously reported dsRNA (dsRNA95-475) and 
heterologous dsRNA (dsRNAeGFP) post 48 hours IMNV infection. Y-axis indicates 
mean survival ± SEM (%) and X-axis indicates days post-IMNV infection. n=90 
animals/treatment except negative control group; n=30 animals.  
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Fig. 11. Confirmation of suppression of IMNV using muscle tissue by qRT-PCR 
analysis. X-axis is treatment and Y-axis is log10 viral genome copy number. Bars 
represent standard error within the sample. n=18 samples/treatment. 
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Table 1. Oligonucleotide primer sequences for RT-PCR, dsRNA synthesis and 
RACE PCR 
Primers Sequence 5’- 3’  
 
RT-PCR to confirm the new IMNV genome 
IMNV26F TTCGTAGGCAAGAACGAAGTGGCT  
IMNV312F GTAGCATTACTTGGCGCATGCAGT  
IMNV643R   ACTATGTGGACATGACACAGGGCA  
IMNV1016R TGATTGTATGCTGCCACCTCCAGA  
IMNV8204R1  CGACTATAACCTAGGGCCAACCGC    
IMNV8210R2   GACTATAACCTAGGGCC  
IMNV7852F TTGGACAAATGGTTCCCGGTCCAA  
 
dsRNA synthesis 
IMNV26T7F TAATACGACTCACTATAGGGTTCGTAGGCAAGAACGAAGTGGCT  
IMNV401T7R TAATACGACTCACTATAGGGTTCGCTATACGCCGAGGTTACAGT  
IMNV233T7F TAATACGACTCACTATAGGGACGAGTCGCATCCTTACGAGAAGT  
IMNV613T7R TAATACGACTCACTATAGGGTCTTACGTGAAGGACGAACGGGAA  
 
5’ RACE of IMNV (Indonesia) 
273F ACGAGTCGCATCCTTACGAGAAG  
452R AGACATCCAATGGTATATGGACAG   
428R TCCAGTTTCTAGCATACAAGCCGG  
C tail F GACATCGAAAGGGGGGGGGGG  
374R  GCCGAGGTTACAGTCGGACTAG  
 
5’ RACE of IMNV (Brazil)  
51F   GCTATGGGGTTTGAGGTTTAGCCG  
163R GAGAACAACAGCTAATCGAGGACG  
243R TACTGCACTTCTCGTAAGGATGCG  
304R AAGTAATGCTACCCGTAACGACGG  
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Primers            Sequence 5’-3’ 
 
3’ RACE of Brazil and Indonesia strain 
3’ RT GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT  
3’ Rev GGCCACGCGTCGACTAGTA  
7945F GAAATTCCAACTGAACCAGCAGTT  
M13F GTAAAACGACGGCCAG  
M13R CAGGAAACAGCTATGAC  
 
 
Table 2. Comparison of sequencing coverage between the new and published IMNV 
sequences  
 Sequencing coverage (fold) 
IMNV sequence Positive strand Negative Strand Total 
IMNV genome (8223 bp)        29.39        26.21 55.60 
5’-new sequence (639 bp)    26.37 21.48     47.85 
Published sequence (7561bp)    29.73 26.67     56.40 
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CHAPTER 3: VARIATION IN VIRULENCE IN GEOGRAPHICALLY 
DISTINCT ISOLATES OF INFECTIOUS MYONECROSIS VIRUS IN 
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Abstract  
The emergence of new viral diseases can cause devastating losses in 
production animal systems including crustacean aquaculture. For example, 
Infectious myonecrosis virus (IMNV) emerged in the last decade and is estimated to 
have caused losses in excess of $1 billion USD since the first outbreak in two 
endemic countries, Brazil and Indonesia. Recently, Next Generation Sequencing of 
IMNV-infected Litopenaeus vannamei revealed the IMNV genome is 8226 bp in 
length as compared to 7561 bp in the initial description by additional of 639 bp at 5’ 
end and 22 bp at 3’end. Bioassays were conducted to compare the virulence of 
IMNV isolates and viral replication was evaluated by qRT-PCR. Comparative 
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bioassay results showed that shrimp that were challenged with IMNV (Indonesia) 
had a survival rate of 13.3% that was significantly lower than 86.7% survival 
observed in shrimp infected with an equivalent dose of ~7.3 x102 viral copy numbers 
µl-1 RNA of IMNV (Brazil) (p=0.0007). Animals challenged with ten times the virus 
inoculum of IMNV (Brazil) showed higher mortality than the lower dose group; 
however, even with this increased of dose, death caused by of IMNV (Brazil) did not 
approach the 100% mortality observed in shrimp infected with IMNV (Indonesia). 
The complete genome sequences of both IMNV isolates were compared and shown 
to differ in 67 bp and 30 amino acid positions. 
Introduction 
Infectious myonecrosis virus (IMNV) emerged in 2002 in farmed Pacific white 
shrimp, L. vannamei, at Pernambuco, in the state of Piaui in northeastern Brazil and 
then spread to other regions of Brazil (Poulos et al. 2006, Andrade et al. 2007, 
Walker & Mohan 2009). Several years after the emergence of IMNV in Brazil, IMNV 
was identified in shrimp by RT-PCR from samples collected in the Situbondo District 
of East Java in Indonesia in 2006 (Senapin et al. 2007, Walker & Mohan 2009), from 
which IMNV subsequently spread to other regions of the country. It is likely that the 
epizootic of IMNV in Indonesia occurred because of transportation and use of 
infected animals from Brazil; indeed IMNV (Brazil) and IMNV (Indonesia) are very 
closely related with genomes have 99.6% identity at nucleotide (nt) level (Poulos et 
al. 2006, Senapin et al. 2007). Clinical signs of IMNV infection include opaque to 
white muscles that start from the ventrum to dorsum of abdominal muscles and a 
mortality rate that reaches up to 70% in shrimp farms (Poulos et al. 2006, Senapin et 
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al. 2007). The consequence of the outbreak in these two countries is expected to 
cause financial losses of more than $1 billion USD (Lightner et al. 2012). Outbreaks 
of this disease thus far have not been reported in any other countries. 
Andrade et al. (2007) reported 100% mortality at 52 days post-infection in a 
bioassay in which 1 gram animals were challenged with IMNV (Brazil) (~1.0 x 104 
IMNV copy numbers µl-1 RNA). The infected animals began to experience increased 
mortality after 40 days post-infection. In contrast, Loy et al. (2012) demonstrated 
100% mortality at 18 days post-infection in a bioassay in which 8-10 gram animals 
were challenged with IMNV (Indonesia) (~3.2 x 103 IMNV copy numbers µl-1 RNA). 
The data indicated that even using the smaller animals as 1 gram challenged with 
the high viral titer, it took nearly two months to cause 100% mortality using IMNV 
(Brazil) while IMNV (Indonesia) reached 100% mortality in shorter time period using 
bigger animals and lower viral titer. The virulence of these two IMNV isolates cannot 
be directly inferred from these data because the experiments were conducted in 
different laboratories with variability attributable to challenge techniques, animal 
source and qRT-PCR technique. We, therefore, conducted bioassays to directly 
compare the virulence of IMNV isolates.  
IMNV is classified in the family Totiviridae because of its characteristic non-
enveloped, double-stranded RNA (dsRNA) genome, and the virus particle with 
icosahedral symmetry that is 40 nm in diameter. The genome originally was reported 
to have 7561 base pairs (bp) (NC_007915.2, AY570982.2; EF061744.1; 7561 bp) 
with two non-overlapping open reading frames (ORFs): ORF 1 and ORF 2 (Poulos 
et al. 2006, Nibert 2007). We used Next Generation Sequencing (NGS) to 
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investigate IMNV infection in lymphoid organ tissue (Chapter 2). The sequence 
revealed that IMNV genome is larger than originally reported; the additional 
sequences include additions to the 5’ end (639 bp) and 3’ end (22 bp) such that the 
genome is 8226 bp in length. The extra sequence at 5’ end results in the expanding 
of the coding region of putative ORF1 of IMNV (Indonesia) by 114 amino acids. The 
novel sequences were confirmed with molecular techniques and the completed 
IMNV genome was submitted to Genbank (IMNV (Indonesia), Accession No. 
KF836757) (Loy et al., Chapter 2). IMNV genome sequences of both IMNV isolates 
were compared and revealed differences at both the nucleotides and amino acid 
level. The studies have shown that the mutation of virus can lead to the increasing of 
viral virulence or attenuation of virus (Cahour et al. 1995, Fayzulin & Frolov 2004, 
Sirigulpanit et al. 2007). It is possible that differences in the coding and non-coding 
regions of IMNV isolates (Brazil and Indonesia) can affect virus virulence.  
Materials and Methods 
Animal Rearing 
Specific Pathogen Free (SPF) juvenile L. vannamei were received from 
Shrimp Improvement Systems (Islamorada, FL, USA) and maintained in a rearing 
facility at Iowa State University. Shrimp were placed in one ton fiberglass tanks filled 
with dechlorinated municipal water and Crystal Sea Marinemix (Marine Enterprises 
International, Baltimore, Maryland). Water conditions were maintained at 25-27 °C, 
salinity 30-35 parts per thousand (ppt), with constant airstone aeration. Each tank 
was equipped with a carbon filter and an oyster shell airlift biofilter. Water quality 
was monitored weekly by measuring ammonia and nitrite levels (Nitriver3, Hach 
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Company, Loveland, CO). Shrimp were fed and monitored for twice a day with 
commercial growout diet and cultured to reach 3-7 grams for bioassays. 
Bioassays 
SPF shrimp sized 5-7 grams were divided into 3 groups of 10 shrimp with 3 
replicates in each group and 10 shrimp for negative controls. Tanks were maintained 
at 29-30 °C. Shrimp were injected intramuscularly with IMNV (Brazil) or (Indonesia) 
diluted 1:100 (~7.3 x102 viral copy numbers µl-1 RNA). Shrimp were fed and 
mortality observed twice daily for 17 days post-infection. Another bioassay study 
was conducted with the smaller animals (3-5 grams) divided into groups (10 shrimp 
in 3 replicates) and 10 shrimp for negative controls. Shrimp were injected 
intramuscularly with IMNV. The experimental groups included IMNV (Brazil) and 
(Indonesia) with ~7.3 x102 and ~7.3 x103 viral copy numbers µl-1 RNA and negative 
control group. Shrimp were monitored regularly until 21 days post-infection. These 
bioassays were repeated twice. Tissue samples were stored in -80 °C prior to qRT-
PCR testing.  
Quantitative Reverse-Transcription PCR 
Quantitative Reverse-Transcription PCR (qRT-PCR) was used to quantify 
virus titer according to protocol adapted from a previously described method 
(Andrade et al. 2007). RNA was extracted from muscle tissue using the RNAeasy 
Minikit (Qiagen) and 3 µl of sample (60 ng/µl) was added to each reaction of One 
Step RT-PCR Master Mix (Qiagen). The one step RT-PCR reaction mixer contained 
5 x Master Mix (5µl), Enzyme mix  (1 µl), dNTP (1 µl), 20 uM of IMNV412F (0.3 µl), 
20 uM IMNV545R (0.3 µl), 10 µM IMNV probe (0.3 µl) and RNase-free water (14.1 
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µl) for a total volume of 25 µl. Thermal cycling was performed with conditions from a 
previous report (Loy et al. 2012) using following conditions: 30 min at 48 °C and 10 
min at 95 °C, followed by 15 s at 95 °C and 1 min at 60 °C for 35 cycles. Each 
reaction was run in duplicate on a BioRad CFX96 Real Time PCR Detection System 
using a standard curve as described previously (Andrade et al. 2007, Loy et al. 
2012).  
Sequencing full-length IMNV (Brazil) 
The full-length IMNV (Brazil) genome was amplified by RT-PCR and 
sequenced as nine overlapping fragments using the primers listed in Table 1. 
Complementary DNAs were generated using Superscript III reverse transcriptase 
(Invitrogen, Carlsbad, CA, USA) following the manufacturer’s instructions. Briefly, an 
aliquot of total RNA (1–2 µg) was mixed with 500 µM of each dNTP and 25 ng of 
primer, and heated at 70 °C for 10 min. After briefly chilling on ice, samples were 
added to 200 units of Superscript III reverse transcriptase in 1x reaction buffer 
(50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 mM MgCl2, 10 mM DTT) and incubated at 
50 °C for 1 h, followed by 70 °C for 15 min. PCR amplifications were performed 
using 1 µl of cDNA template, 0.1 unit of Taq polymerase, 25 ng of each primer and 
each dNTP at 200 µM in 1x PCR buffer (20 mM Tris-HCl [pH 8.4], 50 mM KCl, 
1.5 mM MgCl2). Reactions were performed as follows: 94°C for 3 min, 30 cycles of 
94 °C for 30 sec, 50 °C for 45 sec and 72 °C for 3 min, followed by a final extension 
at 72 °C for 8 min. An aliquot of each PCR product was examined by 1% agarose 
gel electrophoresis, visualized with ethidium bromide and extracted using the 
Purelink gel extraction kit (Invitrogen). Purified DNAs were sequenced in both 
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directions using a 3730x1 DNA sequencer (Applied Biosystems, Foster City, CA, 
USA).  
Statistical analysis 
Survival data and viral copy number were expressed as the mean ± standard 
error. The mean survival data were tested at the end of experiment and the mean 
log viral copy number analyzed by qRT-PCR was compared between each group. 
Survival data obtained from the experiments were analyzed using Student’s t-test. 
One-way ANOVA followed by a Tukey’s multiple comparison test (p<0.05) was used 
to test the significance of mean survival and virus copy number. All statistical 
analysis was conducted using JMP 10 (SAS Institute Inc.).  
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Results 
 
Sequence analysis of IMNV (Brazil and Indonesia)  
When IMNV first was detected in Indonesia, a comparison of the genome as it 
was understood at the time (i.e., 7.5 kb in length) revealed 99.6% similarity between 
IMNV (Brazil) and IMNV (Indonesia). More recently, our group described an 
additional 639 bp of sequence at the 5’end and 22 bp at the 3’ end of the IMNV 
(Indonesia) genome, which was revealed in a high throughput sequencing effort of 
IMNV-infected L. vannamei tissue (Chapter 2). In this study, we endeavored to 
generate full-length IMNV (Brazil) sequence using RT-PCR and discovered that the 
full-length genome of this strain also consists of 8226 bp (Accession No. KJ556923). 
The full-length of IMNV genome differs from the sequences that were previously 
reported in Genbank (NC_007915.2, AY570982.2; EF061744.1; 7561 bp) as shown 
in Fig. 1 (A, B and C). The previously reported IMNV (Brazil and Indonesia) genome 
was described with two ORFs, ORF1 and ORF2. The first ORF (nt 136-4953) 
encodes a protein with a dsRNA-binding motif (DSRM) (nt 136-315, 60 amino acids 
(aa)) and a major capsid protein (MCP) (nt 2248-4953, 901 aa). ORF 2 (nt 5241- 
7490) encodes RNA-dependent RNA polymerase (RdRp) (nt 5241-7490, 749 aa) 
(Poulos et al. 2006, Senapin et al. 2007). The recently revealed additional sequence 
of IMNV genome cause shifts in the nucleotide positions of key features in the 
genome as shown in Table 2. Most importantly, the extra sequence at the 5’ end 
results in a considerable increase in the predicted length of ORF1 in the IMNV 
genome. Originally, ORF1 was predicted to encode 1605 aa; with the addition of 
nucleotides at the 5’ end, IMNV (Indonesia) encodes 1719 aa and IMNV (Brazil) 
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encodes 1708 aa, increasing the coding region by 114 aa and 103 aa as depicted in 
Fig. 1 (A, B and C). Surprisingly, these results suggest that IMNV (Indonesia) 
encodes 11 additional amino acids at the N-terminus as compared to IMNV (Brazil) 
(Fig. 1B, C and D). Coding differences also are evident in the DSRM and the MCP. 
ORF 2 encodes the RdRp and has 11 bp changes that result in 4 aa differences 
between isolates. All together, the two isolates differ by 67 bp and 30 aa as shown in 
Table 2. These sequence differences could be key to the variation in the virulence 
observed in the field and in bioassays.  
Variation in virulence of IMNV isolates 
Shrimp (5-7 gram) were injected intramuscularly with one of the two isolates 
of IMNV. The virus inoculum was standardized by qRT-PCR to contain ~7.3 x 102 
IMNV copy numbers µl-1 RNA (1:100 dilution) in both IMNV (Indonesia and Brazil) 
and study animals were observed for 17 days post-infection. The bioassay results 
showed that shrimp that were challenged with IMNV (Indonesia) had a survival rate 
of 13.3% which was significantly lower than the 86.7% survival rate in shrimp 
exposed to the Brazil strain (p=0.0007) as shown in Fig. 2. Another bioassay study 
was conducted by challenging smaller animals (3-5 grams) (n=60 animals/group for 
all groups except IMNV (Indonesia), n=30 animals/group for ~7.3 x 103 IMNV 
copies) with a ten-fold higher titer of IMNV (Brazil) (~7.3 x 103 IMNV copies) in order 
to determine if higher virus increases mortality in animals challenged with IMNV 
(Brazil). The study was observed for a longer period for 21 days post-infection as 
shown in Fig. 3. Animals that were challenged with ~7.3 x 102 IMNV copy numbers 
µl-1 RNA of IMNV (Brazil) showed significantly different mean survival (68.3%) as 
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compared to 5.0% survival in shrimp exposed to IMNV (Indonesia) (p=0.0004). A 
tenfold increase in the dose of virus with IMNV (Brazil) (~7.3 x 103 IMNV copy 
numbers µl-1 RNA) did not cause 100% mortality within 10 days post-infection as 
shown with and equivalent dose of IMNV (Indonesia) (~7.3 x 103 IMNV copy 
numbers µl-1 RNA). Thus, these bioassays confirm data from the literature that 
suggest that there are significant differences in virulence between IMNV isolates. In 
every experiment, exposure to IMNV (Indonesia) results in more rapid disease 
progression and higher mortality, and therefore higher virulence, than IMNV (Brazil). 
Importantly, IMNV (Indonesia) produces100% mortality in L. vannamei within 10 
days post-infection using our experimental paramaters; this level of mortality was 
never observed during infection with IMNV (Brazil). 
qRT-PCR analysis of virus load in IMNV-infected shrimp 
IMNV virus load was analyzed by qRT-PCR using infected muscle tissue. 
Although there are differences in the mortality between groups, the quantification of 
virus in infected animals showed that with either virus strain, dead animals have 
higher virus loads, with a mean viral titer of 2.02 x 106 IMNV copy numbers µl-1 RNA 
(n=6 samples/group) as shown in Fig. 4. No statistically significant differences were 
observed between the viral load of dead animals between infections with IMNV 
(Indonesia) or (Brazil) (p>0.05). Virus load was also assessed in animals infected 
with IMNV (Brazil) with at either of two doses to compare virus load between 
survivors and dead animals. The results indicated that the dead animals have higher 
virus loads titer than the survivors such that 1.04 x 105, and 1.25 x 106 viral copies 
were observed in survivors and dead animals, respectively (dose ~7.3 x 103 viral 
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copies); in animals exposed to ~7.3 x 102 viral copies, 1.92 x 104 and 2.70 x 106 viral 
copies were observed in survivors and dead animals, respectively). There was a 
statistically significant difference between survivors and dead animals in both viral 
concentration of IMNV (Brazil); ~7.3 x 103 viral copies (p=0.0028) and ~7.3 x 103 
viral copies (p=0.005) as shown in Fig. 5. Thus, these data support bioassay data 
and reveal that virus replication is likely not impaired in IMNV (Brazil) and therefore 
not the primary cause of different virulence observed between the two strains.   
Discussion 
The study presented here highlights genotypic and phenotypic differences in 
IMNV isolates from Brazil and Indonesia. IMNV emerged first in Brazil in 2002, and 
was detected in shrimp in Indonesia in 2006. The effect has been particularly 
devastating in Indonesia, which is home to the biggest shrimp farms in the world. 
The mortality observed in challenge models of both viral isolates was confirmed by 
qRT-PCR to detect virus load in muscle tissue and showed a significant difference in 
virus titer of mortalities and survivors (Fig. 4 and Fig. 5). These bioassays confirm 
data from the literature that suggest that there are differences in virulence between 
IMNV isolates. The genomes of IMNV (Brazil) and IMNV (Indonesia) contain 8 bp 
differences in the 5’ UTRs, the non-coding regions of the IMNV genome. During 
virus replication cycles, ribosomes bind to the extreme 5’ end of the positive strand 
to initiate translation; however, if mutations occur in this region, this can impair 
protein synthesis and lead to attenuation of virus replication (Chatterjee & Pal 2009). 
Secondary structures in the mRNA sequence of the 5’ UTR have been reported to 
be involved in the regulation of RNA replication and translation process of other RNA 
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viruses such as Hepatitis C virus, Dengue virus, and Sindbis virus (Cahour et al. 
1995, Butrapet et al. 2000, Fayzulin & Frolov 2004, Shi ST 2006, Sirigulpanit et al. 
2007). There are 8 bp substitutions in the 5’UTR between strains, which may 
account for the phenotypic differences (mortality) in virulence.  
  The comparison of both IMNV isolates also revealed position differences in 
the initial start codon of ORF 1 as depicted in Fig. 1 (D). In IMNV (Indonesia), the 
predicted start codon (AUG) initiates at the nucleotide position 437 while IMNV 
(Brazil) AUG starts at the nucleotide position of 470 in which increases the length of 
putative ORF1 by 11 amino acids in IMNV (Indonesia). Mutations in 51 nt in the 5’ 
UTR of Sindbis virus (Togaviridae, Alphavirus genus) causes attenuation of viral 
replication in mosquito cells (Fayzulin & Frolov 2004). Moreover, the sequence 
comparison of both IMNV genomes showed that nucleotide polymorphisms affect 
the coding region in ORF 2 that encodes the RdRp. RdRp is key to virus replication 
so, clearly, mutations that occur in this region could affect the replicative capacity 
and therefore virulence of the virus (Gallei et al. 2006). Prior studies have shown 
that point mutations in the RdRp alter replication of West Nile virus (family 
Flaviviridae, genus Flavivirus) (Van Slyke et al. 2012). IMNV is an RNA virus that 
generally has a high rate of mutation associated with a lack a proof-reading ability 
(Steinhauer et al. 1992, Drake 1993). IMNV originated in Brazil and then was 
translocated to Indonesia via the importing of live animals harboring the virus 
(Senapin et al. 2007). During the movement of the disease from South America to 
Asia, it is likely that genetic mutations occurred to enhance viral fitness in a new 
environment, for which there certainly is precedent in other shrimp viruses including 
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WSSV (Zwart et al. 2010); in fact, dramatic size differences in the White Spot 
Syndrome Virus (WSSV) genome (293-312 kb) are involved in WSSV virulence from 
different countries (Zwart et al. 2010). 
Bioassays were conducted in an attempt to evaluate differences in disease 
outcome and virus replication between IMNV isolates. The inoculation of L. 
vannamei with ~7.3 x 102 IMNV copies resulted in significant differences in mortality 
according to IMNV strain. Animals that were challenged with IMNV (Indonesia) 
showed significantly higher mortality rates than IMNV (Brazil) (Fig. 2). Another 
bioassay study was conducted with higher doses of virus and showed that animals 
that received a ten-fold higher dose of IMNV (Brazil) caused higher mortality than 
the lower dose group (~7.3 x 102   viral copies); infection with IMNV (Brazil) never 
caused100% mortality that is seen as a result of infection with IMNV (Indonesia) 
(Fig. 3).  
The data produced in this study did not directly evaluate the direct effect of 
specific IMNV mutations on pathogenesis; these naturally occurring mutations are 
the only available method to compare genomic differences because there is not an 
IMNV infectious clone and there are no existing continuous shrimp cell lines to 
propagate the virus. Insect cell lines including Sf 9 (Spodoptera frugiperda cells) can 
be infected with WSSV (Liu et al. 2007) and a mosquito cell line, C6/36, (Aedes 
albopictus cells) can be infected with Taura Syndrome virus (TSV) (Dhar et al. 
2004); however, there is no report of successful infection of IMNV in insect cell lines. 
Primary cell lines from the hepatopancreas, hemocytes or lymphoid organs (Flegel 
1998, George & Dhar 2010, George et al. 2011) might be an alternative method if 
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the primary cell cultures can be perpetuated and show cytopathic effects as a result 
of IMNV infection. Primary cell culture would facilitate more rigorous comparison of 
IMNV strains.  
Overall, the present study demonstrates the first direct comparison of IMNV 
virulence in geographically diverse isolates. This provides additional insight into 
IMNV biology to include mutations that very likely have an effect on virulence.   
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Fig. 1. A schematic representation of IMNV genome organization (modified from 
(Nibert 2007). A) Previously published information indicated a genome length of 
7561 bp (Accession No. AY570982.2). B) Newly revealed sequence information 
from IMNV (Indonesia) indicates the virus genome length is 8226 bp (Accession No. 
KF836757). C) Newly revealed sequence information of IMNV (Brazil) that 
generated by RT-PCR indicates the virus genome length is 8226 bp (Accession no. 
KJ556923). Based on open reading frame (ORF) prediction, the putative ORF1 of 
IMNV has 1719 and 1708 amino acids (aa) that is 114 aa and 103 aa longer than 
the previously reported sequences (1605 aa) (Indonesia and Brazil, respectively).  
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D) Multiple alignment of predicted amino acids sequences using the Clustal Omega 
program (Sievers et al. 2011). The comparison of both IMNV isolates revealed 11 
additional amino acids in IMNV (Indonesia) at putative ORF 1. Nucleotide positions 
indicate the following genome features; A is 5’ UTR, B is ORF1, C is intergenic 
region, D is ORF2 and E is 3’ UTR.  
 
 
 
 
 
Fig. 2. Shrimp percent survival following the IMNV 1:100 challenge (~7.3 x102   IMNV 
copy number µl-1 RNA), n=30 animals/group.  
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Fig. 3. Shrimp percent survival following the IMNV infection (Brazil and Indonesia) 
with different dilution of 7.30E+02 and 7.30E+03, n=60 animals/group (except IMNV 
(Indonesia) 7.30E+03, n=30 animals/group). 
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Fig. 4. Viral genome copies calculated by qRT-PCR in muscle tissue of dead 
animals post-IMNV infection (n=6 samples/ group). X-axis is treatment and Y-axis is 
log10 viral copies. Bars represent standard error within the sample. No significant 
difference was observed between groups of dead animals (p>0.05).  
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Fig. 5. Viral genome copies calculated by qRT-PCR in muscle tissue of dead and 
survival animals post-IMNV (Brazil) infection, n=12 samples/group (6 survived and 6 
dead animals/group). X-axis is treatment and Y-axis is log10 viral copies.  Bars 
represent standard error within the sample. There are significant differences 
between dead and surviving animals after infection with IMNV (Brazil) in both viral 
titer groups; 7.3E+03 (p=0.0028) and 7.3E+02 (p=0.005). 
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Table 1. Primers used for the RT-PCR amplification and nucleotide sequencing of 
the IMNV (Brazil) genome.  
1Primers for PCR 
and sequencing 
Nucleotide 
positions 
Sequence (5’ to 3’) 
PCR-A-For 1-21 ATTTTCTACATCTGGCCAAGG 
PCR-A-Rev 1148-1169 TGGATGACATTTGTACTTGCAG 
Seq-1A 321-341 ATTACTTGGCGCATGCAGTGG 
Seq-2A 641-662 GAATTAGGTTGAAATTGCCCTG 
PCR-B-For 1041-1063 TTGAGAGTAATCCTGGACCTATC 
PCR-B-Rev 2084-2105 CTTCTCTAGTTAGAACTGGATC 
Seq-1B 1361-1380 GAGGAAGCTATAGAGGCAAC 
Seq-2B 1766-1787 CCTCAATTGCTGTCTTTAGTGG 
PCR-C-For 1921-1943 GGAACAGGTATCAATAACGCCAG 
PCR-C-Rev 2984-3006 GTCATATCAGCTAATACTCTTAG 
Seq-1C 2266-2288 ATCATCAAGCAACGATCACTATG 
Seq-2C 2339-2360 TCATTTCAAGTGGATCTTCTGG 
PCR-D-For 2804-2826 GTCAGTGACGTTACCTACACTAG 
PCR-D-Rev 3946-3946 TGTTGGTTGAATTACTACACGTG 
Seq-1D 3201-3222 TTGAAACACACATTACAGACAG 
Seq-2D 3474-3496 CTGTGTTCTTGAATCAAATGCAG 
PCR-E-For 3826-3849 CGAATCTACTGTACATATTCCAGG 
PCR-E-Rev 4937-4960 TGAATTATCAATTAGTGCTGGTTC 
Seq-1E 4241-4263 ACTGCATGTCTTGCAAACTTAGG 
Seq-2E 4518-4539 CTATCATATGCTGTGTCCCACG 
PCR-F-For 4881-4902 TGCCATGGCCAATGCCAGAAGG 
PCR-F-Rev 5943-5965 CTATTCCAAATACTAACATATAG 
Seq-1F 5361-5381 AGTGGGCACATGCTCAGAGAC 
Seq-2F 5466-5488 CTTGGGTGCCATCATTGCTGTGG 
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1Primers for PCR 
and sequencing 
Nucleotide 
positions 
Sequence (5’ to 3’) 
PCR-G-For 5842-5864 ATACGTTTAATCGACCTTTGGCG 
PCR-G-Rev 6889-6911 CTCGTTATTCTCACTCCTGATGG 
Seq-1G 6242-6263 AAGTAATGACATGGTACAAAGG 
Seq-2G 6425-6447 ATCCCAAGCATAAACAATGTTGG 
PCR-H-For 6796-6820 GTCAATAAGATTGTTAATGCATATG 
PCR-H-Rev 7632-7655 GTCTGATTTCTACTCCATATGATC 
Seq-1H 7147-7169 GAGATATCAGTGACAGGAGTACG 
Seq-2H 7340-7360 AACTTTGTCTGACGTGTCTCG 
PCR-I-For 7226-7249 AACCTTGGAGTCCAAATGATGAAG 
PCR-I-Rev 8203-8226 GACTATAACCTAGGGCCAACCGCA 
Seq-1I 7559-7580 TGCAAACAGATGATATACCTGG 
Seq-2I 7665-7686 ACGTACTGTGTGATCAGTATGG 
 
1Primers A through I denote those used to RT-PCR amplify and/or sequence 
fragments 1 through 9, respectively; For denotes forward PCR primers; Rev denotes 
reverse PCR primers 
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Table 2. IMNV genomes comparison of geographically distinct isolates between 
Brazil and Indonesia.  
Region in 
the 
genome 
Nucleotide positions   Indonesian isolate compared to Brazilian isolate 
Indonesia Brazil 
 
Nucleotide 
differences 
Amino acid 
differences 
5' UTR 1- 436 1-469   8, Gap= 33 NA 
ORF1 437-5596 470-5596 
 
48 26 
DSRM 779-958 779-958 
 
2 1 
MCP 2870-5596 2870-5596 
 
22 6 
Intergenic 5597-5883 5597-5883 
 
NA NA 
ORF2 5884-8133 5884-8133 
 
11 4 
RdRp 5884-8133 5884-8133 
 
11 4 
3'UTR 8134-8226 8134-8226   NA NA 
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CHAPTER 4: COMPARATIVE ANALYSIS OF SUPPRESSION OF 
IMMEDIATE EARLY, EARLY AND LATE GENES OF WHITE SPOT 
SYNDROME VIRUS 
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Abstract 
White Spot Syndrome Virus (WSSV) is one of the most devastating disease 
agents to cultured shrimp. WSSV is a double-stranded DNA virus with a 300 kbp 
genome. WSSV gene expression occurs in a temporally regulated cascade that 
includes immediate-early (IE), early (E) and late (L) genes to facilitate host cell entry, 
initiation of replication and virus particle assembly. Recombinant proteins, RNA 
interference (RNAi) triggers and broad-spectrum immune activators have been 
explored as means to potentiate an antiviral response and thereby protect shrimp 
from White spot syndrome. Our studies and others have shown that double-stranded 
RNA (dsRNA) molecules, specific to capsid protein-coding genes in the WSSV 
genome, provide significant protection from disease and mortality. We postulated 
that targeting immediate early or early genes could provide more protection against 
disease by shutting down virus replication more rapidly and thereby reducing the 
burden of infection on the host cell machinery. RNAi triggers were generated to 
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target an immediate early (wssv403) and an early (wssv477) as compared to a late 
gene (VP15). Animals that were subjected to injection with dsRNA477 or 
dsRNAVP15 showed high survival (95.5% and 90.0%, respectively) at 10 days post-
infection. By contrast, dsRNA403 did not provide a significant protection against 
WSSV infection. In addition, the viral copy number detected in dsRNA477 and 
dsRNAVP15-injected shrimp was lower than the control and dsRNAeGFP groups 
suggesting the inhibitory effects of virus replication by dsRNA. To carry this a step 
further, we conducted a minimum protective dose study. Shrimp that received a 
dose of 0.1 µg of dsRNA477 showed 74.0% survival post-infection. A dose ten times 
higher (1 µg) was necessary to achieve 64.4% survival using dsRNAVP15.  
Introduction 
In the last two decades, the global crustacean fisheries industry witnessed a 
dramatic increase in production (measured in millions of metric tons) as a result of 
widespread adoption of the Pacific white shrimp as the culture species of choice 
(see Bondad-Reantaso et al. 2012). Epizootics of disease caused by virus infections 
are the primary obstacle to productivity and yield in these fisheries (Lightner 2011b). 
White spot disease causes the majority of losses and remains the most significant 
infectious disease in shrimp production systems. WSSV outbreaks cause up to 
100% mortality in cultured shrimp within 3-5 days. 
White spot disease was first reported in shrimp farms in northern Taiwan in 
1992 (Chou et al. 1995); within a few years, it spread to several shrimp farming 
countries (Lo et al. 1996, Wang et al. 1999). The spread of WSSV threatens the 
success and further development of shrimp aquaculture worldwide because it 
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causes tremendous economic losses, in fact an estimated $15 billion since 1992 
(Lightner et al. 2012). Standard disease control measures for shrimp production 
include the use of Specific Pathogen Free (SPF) animals produced through a 
judicious quarantine procedure to guarantee disease-free status, selective breeding 
from families of animals that have desirable growth and disease resistance traits, 
and the rigorous use of hatchery and farm biosecurity measures (see Moss et al. 
2012). Unfortunately, family-based selective breeding has had limited success in the 
case of resistance to WSSV because of limited heritability of disease resistance 
traits (Moss et al. 2012) and disease outbreaks continue to occur despite the 
availability of SPF stocks and use of on-farm biosecurity. As a result, there is a very 
real need to develop alternative disease control strategies for WSSV.  
WSSV is large, enveloped virus with a circular double-stranded DNA (dsDNA) 
that has a genome size of approximately 300 kbp (van Hulten et al. 2001, Yang et al. 
2001). The WSSV genome has at least 181 putative open reading frames (ORFs) 
(van Hulten et al. 2001) and it is classified in the genus Whispovirus, family 
Nimaviridae (Mayo 2002). WSSV gene expression occurs in a temporal cascade 
related to host cell entry, replication and capsid assembly. As such, these gene 
production clusters include immediate-early (IE), early (E) and late (L) genes. WSSV 
IE genes can be expressed independently in the absence of viral proteins by utilizing 
host cell replicative machinery; expression of IE genes can be detected from 2 hours 
post-primary infection (Liu et al. 2005). Viral E genes usually encode for regulatory 
proteins that are necessary for L gene expression (Han et al. 2007). Viral L genes, 
including structural genes like capsid proteins are found in the late stages of 
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infection of cells, at least 16-24 hours post-infection (Leu et al. 2009, Sanchez-Paz 
2010).   
Significant efforts have been made to develop antiviral vaccines using 
different techniques such as inactivated WSSV vaccines, recombinant protein 
vaccines and DNA vaccines (Namikoshi et al. 2004, Vaseeharan 2006, Rout et al. 
2007). However, currently there are no effective vaccines that are commercially 
available to control and mitigate WSSV outbreaks. Robalino et al. (2005) first 
reported the induction of an antiviral state by dsRNA in the shrimp Litopenaeus 
vannamei. Since then, RNA interference has been used extensively to demonstrate 
the function of genes in the WSSV genome (Robalino et al. 2004, Robalino et al. 
2005, Westenberg et al. 2005a, Robalino et al. 2007, Xu et al. 2007, Raja et al. 
2010, Sarathi et al. 2010, Mejía-Ruíz et al. 2011). Most of these studies targeted 
WSSV structural genes including VP28, VP19, VP24 and VP15 (Westenberg et al. 
2005a, Wu et al. 2007b, Attasart et al. 2009) that are expressed at the late stage of 
virus infection (Leu et al. 2009). We reasoned that another strategy that could be 
employed in order to improve the efficacy of RNAi for the purposes of developing a 
commercially viable WSSV vaccine would be to target early gene expression instead 
of structural genes; the idea being that suppressing these transcripts could mitigate 
some of the adverse effects of virus use of host cell machinery by interfering with the 
virus earlier in the infection cycle, and that these transcripts could be easier to target 
using RNAi because they would be in lower transcript abundance than Late, 
structural genes. Only one study has directly evaluated the efficacy of targets other 
than structural genes (Wu et al. 2007b, Attasart et al. 2009). Attasart et al. (2009) 
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developed RNAi targets to genes across the WSSV genome and reported promising 
results from suppression of several genes including the early gene, ribonucleotide 
reductase small subunit (rr2) gene, with or without PmRab 7 (cellular genes that 
involving in endocytosis of viral entry), against WSSV showed 95% survival in 
Penaeus monodon, the Black tiger shrimp. Because the WSSV genome is so large, 
and potential for protection after RNAi-based suppression has been investigated for 
a fraction of the 181 total ORFs, there is little doubt that effective antiviral molecules 
against WSSV remain to be discovered. The purpose of our study was to compare 
the efficacy RNAi targets in the immediate early, early or late gene to provide 
protection from disease in WSSV infected Litopenaeus vannamei.  
Materials and Methods  
Shrimp Rearing 
Specific pathogen free (SPF) L. vannamei were obtained from Shrimp 
Improvement Systems (Islamorada, FL, USA) and reared in a bio-secure animal 
holding facility at Iowa State University. Shrimp were reared in 1000L tanks 
containing artificial seawater, an oystershell airlift biofilter, and an activated carbon 
filter. 
Preparation of Virus Inoculum  
Virus inoculum was prepared based on Hasson et al. (1995). Tissue from 
WSSV infected animals was homogenized in sterile TN buffer (0.02 M Tris-HCl, 0.4 
M NaCl, pH 7.4) and clarified through three centrifugation steps. Supernatant was 
transferred into a new tube after each centrifugation step: 14,000 × g for 30 min; 
15,000 × g for 15 min; and 25,000 × g for 60 min (Hasson et al. 1995). The final 
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supernatant was diluted 1:10 with 2% saline and filtered through a 0.2 micron filter. 
A 1000-fold dilution of the stock (~6.38x105 WSSV copies ul-1 DNA) was used as the 
viral challenge dose for the experiments.  
Double-stranded RNA Synthesis 
Template DNA for dsRNA production was extracted from virus infected 
shrimp using the DNeasy kit (Qiagen, Valencia, CA, USA) for a template of the 
dsRNA. Primers containing T7 promoter sites were designed to amplify PCR 
products that targeted VP15 (GenBank Accession No. DQ681072.1), wssv403 
(GenBank Accession No. AF332093.1), and wssv477 (GenBank Accession No. 
NC_003225.1). Primers used to produce the template for dsRNA targeting wssv403 
(dsRNA403) were: 5′-TAA TAC GAC TCA CTA TAG GGG ACC AGT TCC AAC 
CCA AGA A -3′ and 5′-TAA TAC GAC TCA CTA TAG GGC CTG TCA AAC GGG 
ATA GCT G -3′. Primers used to synthesize the template for dsRNA targeting 
wssv477 (dsRNA477) were: 5′-TAA TAC GAC TCA CTA TAG GGA CCT TTG TCG 
ACT CGT GGA A -3′ and 5′-TAA TAC GAC TCA CTA TAG GGG GGC ACA ACA 
AAT CAC AAT G -3′. Primers used to amplify dsRNAVP15 were 5′- TAA TAC GAC 
TCA CTA TAG GGA TGA CAA AAT ACC CCG AGA T-3′ and 5′- TAA TAC GAC 
TCA CTA TAG GGT TAA CGC CTT GAC TTG CGG ACT C-3′. Primers used to 
amplify eGFP (enhanced Green Fluorescent Protein) to generate dsRNAeGFP were 
5’-TAA TAC GAC TCA CTA TAG GGA GAA TGG TGA GCA AGG GCG AGG AGC 
TGT-3’ and 5’-TAA TAC GAC TCA CTA TAG GGA GAT TAC TTG TAC AGC TCG 
TCC ATG CCG-3’ (Loy et al. 2012). 
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  PCR products were purified using the Gel/PCR DNA Fragments Extraction kit 
(IBI Scientific, Peosta, IA, USA) and were sequenced prior to being used as 
template material for dsRNA synthesis. dsRNA was prepared using the Ambion 
Megascript RNAi Kits (Life technologies, Grand Island, NY, USA) following the 
manufacturer’s instructions. 8 µl of PCR product was mixed with 2 µl ATP, 2 µl CTP, 
2 µl, GTP, 2 µl UTP, 2 µl Buffer, and 2 µl of enzyme mix into a total of 20 µl per 
reaction. The mixture was incubated at 37 °C for 12 hours. dsRNA products were 
then incubated for 1 hr with DNase I and RNase, and purified through column 
centrifugation. dsRNA products were subjected to gel electrophoresis and quantified 
using a NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA). 
Bioassays 
 3-5 g SPF shrimp were stocked in tanks containing 200 L synthetic seawater 
and an oystershell airlift biofilter. Tanks were maintained at 28 ppt salinity and 28 °C. 
Shrimp were divided into six experimental groups. Each tank contained 10 shrimp 
and a total of 30 shrimp for each treatment were used in each replicate of the 
experiments; the negative control group contained 10 shrimp. Following acclimation 
for 48 hours, each shrimp was injected intramuscularly with 2 µg dsRNA403, 
dsRNA477, dsRNAVP15, or a heterologous dsRNA control targeting eGFP. At 72 
hours post-dsRNA injection, shrimp were challenged with WSSV including positive 
control group. Shrimp that were not subjected to any dsRNA treatments or WSSV 
challenge were used as a negative control. Mortality data were recorded for 10 days 
post-infection and dead shrimp were collected daily and stored in -80 °C freezer to 
be tested for the presence of WSSV by qPCR.  
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Minimal protective dose against WSSV 
3-5 g SPF shrimp were divided into eight experimental groups including 
different doses of dsRNA, positive and negative control group. Each group was 
represented by three replicate tanks with 10 shrimp per replicate. Shrimp received 
different doses (2 µg, 1 µg and 0.1 µg) of dsRNA477 or dsRNAVP15 or were 
inoculated with 2% NaCl in the case of the positive control group. Following the 
dsRNA or 2% NaCl administration, shrimp were challenged with WSSV at 72 hours 
post-injection dsRNA. Shrimp were monitored for mortality twice a day and dead 
shrimp were removed daily and stored at -80 °C to be tested for the presence of 
WSSV by qPCR. These studies were completed in triplicate. 
Quantitative Real Time-PCR 
 DNA template was extracted from gills of an individual shrimp and 
homogenized using a QIAShedder column (Qiagen) followed by extraction with a 
DNeasy blood and tissue kit (Qiagen). Moribund shrimp for each treatment were 
tested for the presence of WSSV. DNA template from each sample was eluted with 
50 µl nuclease free water. Quantitative Real Time-PCR reaction was performed as 
described previously by Durand & Lightner (2002). The Quantitect Probe kit 
(Qiagen) was used and a mixture reaction was prepared following manufacturer’s 
instructions. Briefly, 3 µl of DNA template was mixed with 12.5 µl of Master Mix, 0.5 
µl of Taqman probe, 1 µl WSSV forward primer (20 µM), 1 µl WSSV reverse primer, 
and 7 µl nuclease free water for a total reaction of 25 µl. Primers used to detect the 
presence of WSSV were WSS1011F: 5′-TGG TCC CGT CCT CAT CTC AG-3′ and 
WSS1079R: 5′-GCT GCC TTG CCG GAA ATT A-3′ and the TaqMan probe 
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sequences were 5′-FAM-AGC CAT GAA GAA TGC CGT CTA TCA CAC A-TAMRA-
3′ (Durand & Lightner 2002). This reaction was then run in two replicates on a 
BioRad CFX96 Real Time PCR machine (BioRad, Hercules, CA, USA). Real time 
PCR thermal cycling parameters included: 15 min at 95 °C followed by 40 cycles of 
15 s at 95 °C, and 1 min at 60 °C. Virus copy number was calculated using CFX 
Manager Software (BioRad) according to a standard curve. 
Statistical analysis 
 The survival rate and the virus copy number data were analyzed by JMP 9 
software (SAS Institute Inc. Cary, NC, USA). A One-way ANOVA, followed by a 
Tukey’s multiple comparison test, was performed to find significant differences 
among treatment and control groups.  
Results 
Protection of shrimp mortality against WSSV  
To examine the protective effects of dsRNA against WSSV infection, the 
mortality of shrimp injected with dsRNA specific to wssv403, wssv477, or VP15 was 
compared to the control groups after WSSV challenge (Fig.1). Shrimp injected only 
with WSSV (positive control group) showed 0% survival at 10 days post-challenge 
with WSSV. Shrimp that were injected with dsRNAeGFP also showed 0% survival at 
10 days post-challenge. Shrimp injected with dsRNA403, dsRNA477 and 
dsRNAVP15 showed 61.1%, 95.5%, and 90.0% survival at 10 days post-challenge 
with WSSV, which was significantly different from the untreated positive controls and 
shrimp injected with dsRNAeGFP; dsRNA403 (p=0.0003), dsRNA477 (p<0.0001), 
and dsRNAVP15 (p<0.0001). The percent survival of dsRNA403 is significantly 
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lower from those of dsRNA477 and dsRNAVP15 groups at 10 days post-WSSV 
challenge (p=0.0069 and p=0.0286).  No mortality was observed in the negative 
control group. Our data show that amongst the dsRNA groups, dsRNA477 and 
dsRNAVP15 provided the most effective protection against WSSV challenge.  
Inhibition of WSSV replication  
To investigate the suppression of virus replication by dsRNA, the copy 
number of virus in the dsRNA-injected shrimp was compared to that in control 
groups (dsRNAeGFP and positive control groups). WSSV was detected and 
quantified by using quantitative Real Time PCR according to Durand & Lightner 
(2002). Virus loads in the positive control and dsRNAeGFP groups were 1.68x108 
and 5.93x107 WSSV copy numbers µl-1 DNA, respectively, which was not 
significantly different (p=0.9580). Although the percent survival of dsRNA403 group 
is significantly higher than those of positive control (p<0.0001) at 10 days post 
WSSV challenge, the viral copy number of dsRNA403 group (mean 7.53x106 WSSV 
copy numbers µl-1 DNA) was not significantly different from the positive control 
(p=0.2754) and dsRNAeGFP group (p=0.6581). Amongst the dsRNA injected 
groups, dsRNA477 and dsRNAVP15 groups (mean 5.17 and 9.85x102 WSSV copy 
numbers µl-1 DNA, respectively) showed the lowest virus load as would be expected 
based on decreased mortality in these groups, which does represent a statistically 
difference from the virus copy number observed in the dsRNAeGFP group 
(p<0.0001). The virus copy number of dsRNA477 group was not significantly 
different than the dsRNAVP15 group.  
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Minimal protective dose of dsRNA477 and dsRNAVP15 against WSSV 
To test the possibility that suppression of an early stage gene requires less 
dsRNA trigger to control white spot syndrome, shrimp were subjected to different 
concentrations (2 µg, 1 µg and 0.1 µg/shrimp) of dsRNA477 and dsRNAVP15; these 
two dsRNAs were of particular interest based on initial results (above) that showed 
both significant protection from disease and significantly reduced virus loads 
according to qPCR. Animals were challenged at 72 hours post-injection with either 
dsRNA. The results demonstrate that shrimp that received dsRNA477 at doses of 2 
µg, 1 µg and 0.1 µg/shrimp showed 97.0%, 96.0% and 74.0%, survival, respectively, 
all of which were significantly different (p<0.0001) from the positive control group 
which showed 1% survival (Fig. 3). Shrimp that received dsRNAVP15 at a dose of 2 
µg, 1 µg/shrimp exhibited significantly different survival from the positive control 
group (p<0.0001) with average survival of 78.9% and 64.4%, respectively. However, 
the dsRNAVP15 group that was provided with 0.1 µg showed 8% survival which was 
not significantly difference from the positive control group (p=0.9954). Thus, a dose 
of dsRNA477 as low as 0.1 µg/shrimp provided significant protection from white spot 
disease, and ten times the amount was required to provide comparable protection 
using dsRNAVP15.  
Muscle tissues were collected from the surviving or the dead animals at 7-10 
days post-infection and assayed by qPCR to determine the effect of virus load as 
measured by virus copy number (Fig. 4). The data show that pre-exposure to either 
dsRNA477 (2 µg and 1 µg/shrimp, mean 2.3x101 and 7.15x101 WSSV copy 
numbers µl -1 DNA, respectively) or dsRNAVP15 (2 µg and 1 µg/shrimp, mean 
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2.58x101, 5.12x101 WSSV copy numbers µl-1 DNA, respectively) results in 
significantly fewer virus copies in muscle tissue of L. vannamei as compared to the 
control group, (mean 2.48x108 WSSV copy numbers µl-1 DNA) (p=0.002). In 
contrast, groups exposed to only 0.1 µg of either dsRNA477 or dsRNAVP15 had a 
mean of 3.32x102 WSSV copy numbers µl-1 DNA or 1.56x108 WSSV copy numbers 
µl-1 DNA respectively, such that only the copy number in the group of dsRNA477 
was significantly different from positive control group (p=0.002) as compared to 
dsRNAVP15 (p=0.6687). The data reveal that shrimp that received dsRNA477 and 
dsRNAVP15 at the two highest doses had high protection as measured by low virus 
copy numbers. This study also demonstrates that dsRNA477 can be provided with 
as little as 0.1 µg/shrimp.  
Discussion 
RNA interference (RNAi) is a highly conserved pathway for antiviral defense 
and gene regulation in plants, animals, and fungi. The RNAi pathway begins with the 
long double-stranded RNA that can be introduced exogenously or is produced as a 
function of virus replication. During an antiviral response in penaeid shrimp, the 
dsRNAs are processed by RNase-III-like enzymes (Dicer) into small RNA duplexes 
that function as small interfering RNA (siRNA) (Labreuche & Warr 2013). These 
duplexes are then unwound and one strand (the guide strand) is loaded into a 
protein complex (RNA-induced silencing complex or RISC) after the recruitment of 
Argonaute proteins (Labreuche & Warr 2013). In the last step, the guide strand 
complexes with the messenger RNA (mRNA) target based on sequence identity 
between the mRNA and the guide strand to induce post-transcriptional gene 
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silencing (Labreuche & Warr 2013). In shrimp, different sets of Dicer and Argonaute-
encoding proteins have been identified, thereby demonstrating the biochemical 
capability of these animals to carry out the RNAi pathway (Unajak et al. 2006, 
Dechklar et al. 2008, Labreuche et al. 2010).   
There are ample data to support the importance and robust nature of RNAi as 
an antiviral response in penaeid shrimp. In the absence of deliberate and systematic 
interrogation of the nuances of the RNAi pathway, there is a great deal known about 
RNAi activation as a result of dsRNA injection or oral administration followed by 
virus challenge. Based on previous studies, dsRNA and siRNA specific for viral 
genes suppress virus replication for WSSV (Robalino et al. 2005, Xu et al. 2007, 
Attasart et al. 2009, Sarathi et al. 2010, Mejía-Ruíz et al. 2011, Bartholomay et al. 
2012, Loy et al. 2012),  Yellow head virus (Tirasophon et al. 2005), IMNV (Loy et al. 
2012) Taura syndrome virus (Tirasophon et al. 2005) and Penaeus monodon 
densovirus (PmDNV) (Attasart et al. 2010). Therefore, the applications of RNAi to 
control shrimp disease caused by viruses is an attractive approach to produce a 
commercial product to prevent the outbreak of many shrimp diseases in the farms.  
Most WSSV early genes encode enzymes involved in virus replication and 
nucleotide metabolism (Sanchez-Paz 2010); the gene that was explored in this 
study, wssv477, is the only WSSV early gene that has  been reported to possess a 
regulatory function (Han et al. 2007). In our study, the WSSV genes wssv403, 
wssv477, and VP15 were chosen as RNAi targets based on temporal expression 
associated with the stage of infection. The results demonstrated that injection of 
RNAi triggers corresponding to wssv477 (early gene) and VP15 (late gene) showed 
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a significant reduction in mortality 10 days after WSSV challenge when compared to 
controls (Fig. 1). Wssv477 transcripts can be detected at increasing levels from 2 to 
72 hours post-infection with expression of the corresponding protein product 
detected by 6 hours post-infection (Han et al. 2007, Wu et al. 2007a). Our results 
show that targeting the early genes, wssv477 indeed confers significant protection 
against WSSV. This result agrees with previously reported data that targeted the 
WSSV early gene, ribonucleotide reductase small subunit (rr2) (Attasart et al. 2009). 
The late gene, VP15, is one of the two major nucleocapsid proteins that comprise 
the WSSV nucleocapsid structure, and when targeted with RNAi provides protection 
against WSSV. VP15 was reported to have a clear preference for supercoiled DNA 
in lieu of double-stranded RNA, single-stranded RNA or single-stranded DNA 
(Witteveldt et al. 2005). This suggests that VP15 is involved in the condensation and 
packaging of the genome in the nucleocapsid (Witteveldt et al. 2005, Leu et al. 
2009). Both 477 and VP15 dsRNA-treated groups showed significant reduction in 
virus copy number as compared to the other groups (Fig. 2). The significant 
reduction in copy number may indicate the inhibition of viral replication in the shrimp 
by both dsRNA treatments. Thus, these data support the essential function of these 
two genes in virus replication.  
Immediate early genes of DNA viruses like WSSV and the baculoviruses 
encode proteins that are important in activating the expression of viral early and late 
genes, altering host gene expression, and evading host immune responses 
(Sanchez-Paz 2010). The data show that dsRNA that targets wssv403 (early gene) 
induced protection against WSSV, but the survival of dsRNA403 vaccinated animals 
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began to decline significantly 5 days post-WSSV challenge. Wssv403 encodes a 
protein with a RING-H2 finger motif that plays an important role in the ubiquitination 
pathway. However, there are three other proteins (wsv199, wsv249 and wsv222) 
that also predicted to have a similar RING-H2 finger motif (Leu & Lo 2011). Thus, 
knocking down only wssv403 might not be sufficient to inhibit viral replication 
because there are other proteins involved in the ubiquitination pathway that may 
serve as an alternative pathway for replication (Leu & Lo 2011). Ubiquitin proteins 
are commonly found in almost all tissue types of eukaryotic organisms (Pickart & 
Eddins 2004). 
The inhibitory effects of dsRNA targeting WSSV early, immediate early or late 
genes may not depend on whether the genes are expressed on the early stage or 
later stage of viral infection. Attasart (2009) suggested that the protective degree of 
dsRNA that targets a specific WSSV gene might be correlated with the gene function 
over the course of viral infection. The dsRNA that targeted immediate early genes 
ie1 and DNA pol did not show any viral inhibition, however, dsRNA that targeted 
immediate early gene ie3 and early gene rr2 showed a viral inhibition, making a 
temporal association with gene transcription and protection unclear (Attasart et al. 
2009). 
In a minimal protective dose study, shrimp were administered with different 
doses of dsRNA (2, 1 and 0.1 µg/shrimp) of dsRNA477 and dsRNAVP15, the data 
suggested that sequence specific of dsRNA of early gene, wssv477, can reduce the 
mortality from WSSV using as minimal dose as 0.1 µg/shrimp (Fig. 3). The qPCR 
also confirmed that using the dose of 0.1 µg/shrimp can inhibit viral replication and 
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significantly from positive control group (p=0.0234) (Fig. 4). However, the similar 
dose of dsRNAVP15 did not show significant protection against WSSV and a dose 
ten times higher (1 µg) was necessary to achieve 64.4% survival. Thus, the function 
of target genes may play a significant role in the degree of protection induced by 
antiviral RNA interference. The lower dose of dsRNA that can mitigate viral disease 
could contribute to the cost-effective of vaccine production resulting in benefit to the 
crustacean fisheries industry. 
Antiviral molecule approaches to manage WSSV by using dsRNA is probably 
a safe approach to reduce the impact on non-target organisms, because dsRNA is 
developed specifically to target the WSSV transcripts. In addition, dsRNA reduces 
the ability of the virus to replicate as shown by the low virus copy number after the 
application of dsRNA in the shrimp when compared to the positive controls. This 
would ultimately reduce the amount of virus shed in the environment and reduce the 
ability for virus transmission in ponds. These advantages are certainly desirable for 
the development of potential control agents for WSSV. However, additional research 
is still needed to assess the environmental risk and food safety of the RNAi 
treatment.  
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Fig. 1. Survival rate (%) of shrimp injected with dsRNAs (dsRNA403, dsRNA477, 
dsRNAVP15 or dsRNAeGFP) and challenged with WSSV at 72 hours after dsRNA 
injection. Each point represents the mean and standard error of values obtained 
from three replicates. A) Shrimp survival post administration of different dsRNAs; 
dsRNA477, dsRNA403 and dsRNAVP15. B) Shrimp survival post administration of 
dsRNAeGFP, positive controls and negative controls (injected with 2% NaCl). C) 
Overall percent shrimp survival at the termination day of study (10 days post- 
infection) from three replicates. All treatment groups have 90 animals/treatment 
except negative control group has 30 animals/treatment from three replications. 
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Fig. 2. Viral copy number data of each treatment (n=18 sample/treatment). DNA was 
extracted from each shrimp and quantitative Real Time PCR was performed to 
detect the presence of WSSV. Data shown in the graphs were means with the 
standard error bars from three replications. 
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Fig. 3. Survival rate (%) of shrimp that intramuscular injection with different doses of 
dsRNA477 and dsRNAVP15 (2, 1 and 0.1 µg/ shrimp) and challenged with WSSV at 
72 hours post-dsRNA injection. Each point represents the mean and standard error 
of values obtained from three replicates with a total of 90 shrimp per treatment. A) 
Shrimp survival post administration of various doses of dsRNA477. B) Shrimp 
survival post administration of various doses of dsRNAVP15. C) Survival of negative 
control group that injected with 2% NaCl and positive control post-WSSV infection. 
D) Overall percent shrimp survival at the termination day of study (10 days post- 
infection) from three replicates. All treatment groups have 90 animals/treatment 
except the negative control group which has 30 animals/treatment from three 
replications.  
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Fig. 4. Confirmation of suppression of WSSV replication by qPCR (n=6 
samples/treatment). Muscle tissues were collected from shrimp that were 
administered with different doses of dsRNA (2, 1 and 0.1 µg/shrimp) of dsRNA477 
and dsRNAVP15. Data shown in the graphs were means with the standard error bar 
of log10 of WSSV copies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
2 1 0.1  2 1 0.1
0
2
4
6
8
10
Lo
g 1
0 
vi
ra
l c
op
ie
s
dsRNAVP15dsRNA477 +
(µg)
	   120	  
CHAPTER 5: DIRECT DELIVERY OF DOUBLE STRANDED RNA 
INTO THE FOREGUT LUMEN OF LITOPENAEUS VANNAMEI 
DEMONSTRATES PROTECTION AGAINST WHITE SPOT 
SYNDROME VIRUS AND INFECTIOUS MYONECROSIS VIRUS 
 
 
A paper to be submitted to Diseases of Aquatic Organisms 
 
Duan S. Loy1, J. Dustin Loy3, Mark A. Mogler4, D.L. Hank Harris1, 4, 5, 6,  
Lyric C. Bartholomay2  
 
1Department of Veterinary Microbiology and Preventive Medicine, Iowa State 
University, Ames IA 50011, USA  
2Department of Entomology, Iowa State University, Ames IA 50011, USA 
3School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-
Lincoln, Lincoln NE 68583, USA 
4Harrisvaccines, 1102 S. Hills Dr. Suite 101, Ames IA 50010, USA 
5Department of Animal Science, 11 Kildee Hall, Iowa State University,  
Ames IA 50011, USA  
6Department of Veterinary Diagnostic and Production Animal Medicine,  
Iowa State University, Ames IA 50011, USA 
 
 
Abstract 
Double-stranded RNA (dsRNA) is a potent trigger for induction of an antiviral 
RNA interference (RNAi) response and has been shown to protect penaeid shrimp 
from infection with a wide range of DNA and RNA viruses. White Spot Syndrome 
Virus (WSSV) and Infectious myonecrosis virus (IMNV) are two particular significant 
viral diseases that cause large economic losses in shrimp aquaculture. Vaccination 
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is a possible mean to prevent large-scale outbreaks. Intramuscular injection is 
routinely used to evaluate shrimp vaccine efficacy. As an alternative, reverse gavage 
can be utilized to directly deliver dsRNA into the foregut lumen of shrimp. We have 
developed RNAi triggers that effectively to protect shrimp against either WSSV or 
IMNV. These dsRNAs were mixed with food coloring dye to facilitate the observation 
of dsRNA gavage into the gut. These experiments demonstrate that the introduction 
of specific anti-viral dsRNA via reverse gavage can elicit statistically significant 
(p<0.05) protection against both IMNV and WSSV virus-induced mortality following 
infection. Delivery by this route elicits protection comparable to vaccination by 
intramuscular injection, and indicates that shrimp possess a mechanism to uptake 
dsRNA from the gut lumen. These data also demonstrate that viral gene specific 
dsRNAs significantly reduce viral replication in vivo.  
 
Introduction 
Infectious diseases caused by viruses are a major cause of economic losses 
in cultured shrimp, with cumulative losses of more than $15 billion USD (Lightner 
2011a, Lightner et al. 2012). White Spot Syndrome Virus (WSSV), which first 
emerged in Southeast Asia in 1992 and has spread throughout shrimp culturing 
areas across the world (Lo et al. 1996, Flegel 1997, Wang et al. 1998, Lightner 
2011a). Infectious myonecrosis virus (IMNV) emerged in the last decade in Brazil 
and spread to Indonesia, and it is expected to cause an economic loss of more than 
$1 billion USD (Lightner et al. 2012). WSSV is a very large, enveloped, double-
stranded DNA (dsDNA) virus. The viral genome size is around 300 kbp and it is 
classified in its own genus, Whispovirus, in the family, Nimaviridae. In contrast to 
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WSSV, IMNV is a small, non-enveloped, double-stranded RNA (dsRNA) virus with 
genome size around 8 kb that is classified in family Totiviridae (Poulos et al. 2006, 
Loy et al, Chapter 2). 
The clinical signs of disease cause by WSSV are white spots on the 
carapace, red to pink discoloration of the body, lethargy, abnormal swimming 
behavior, reduced feed consumption and ultimately death (Lo et al. 1996, Lo & Kou 
1998, Mohan et al. 1998). IMNV-associated clinical signs of disease include white 
opaque abdominal muscle, red tail fans, lethargy and decreased feed consumption 
(Poulos et al. 2006, Senapin et al. 2007). WSSV infected shrimp ponds have high 
mortality, up to 100%, within 3-10 days post-infection under ideal conditions. IMNV 
causes less mortality than WSSV, and ranges from 40-70% (Chou et al. 1995, 
Poulos et al. 2006, Senapin et al. 2007). These two viruses can co-infect shrimp as 
was recently demonstrated in farms in Northeastern Brazil (Feijó et al. 2013).  
Selective breeding and pathogen exclusion via biosecurity systems are used 
to reduce the impact of virus outbreaks in the shrimp farming industry. Shrimp 
vaccines have been developed using various modalities and delivery systems 
including formalin inactivated virions (Namikoshi et al. 2004), subunit protein 
vaccines (Vaseeharan et al. 2006), DNA vaccines (Rout et al. 2007) and dsRNA 
vaccines (see Bartholomay et al.2012). These vaccine studies have shown that 
protection and enhancement of immune responses in penaeid shrimp against virus 
infections is possible, and that shrimp immunity is more complex than previously 
understood (Johnson et al. 2008). RNA interference (RNAi) is undoubtedly key to 
the antiviral response as was first demonstrated by Robalino et al. (2004, 2005). To 
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test this, an intramuscular injection of in vitro synthesized dsRNA that targets 
specific WSSV genes provided protection against lethal challenge by intramuscular 
injection (Robalino et al. 2005). Other studies have shown that various nucleic acid 
vaccines provide significant protection against viral infection such as WSSV, IMNV, 
Yellow head virus (YHV), Penaeus stylirostris densovirus (PstDNV) (Robalino et al. 
2004, Robalino et al. 2005, Yodmuang et al. 2006, Robalino et al. 2007, Ho et al. 
2011, Bartholomay et al. 2012, Loy et al. 2012). However, these studies used an 
injection route, which is impractical in the field.  
An oral vaccine is the ideal for vaccine delivery system in aquatic animal 
production systems. However, one of the major impediments of developing an oral 
vaccine delivery system is that gut environment of animals may cause degradation 
or inactivation of nucleic acid vaccine components rendering them ineffective. Thus, 
an alternative reverse gavage method was utilized to directly deliver dsRNA into the 
foregut lumen of shrimp in order to determine if dsRNA targeted to WSSV and IMNV 
structural genes can establish protection against virus challenge. This technique 
allows us to test the efficacy of a dsRNA vaccine, at a specific dose, in the absence 
of uncontrolled variables that exist with per os delivery feeding; this includes the 
issue of dose based on feed uptake, heterogeneity of distribution of the vaccine on 
feed, release of vaccine from feed, and potential degradation of the vaccine as a 
result of mechanical processing of the feed through gastric sieve and digestive 
enzymes in the gut. Reverse gavage is a method that has been employed for 
disease challenge in penaeid shrimp; for example, Aranguren et al. used reverse 
gavage to challenge shrimp with the enteric bacterial pathogens, as necrotizing 
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hepatopancreatitis bacterium (NHP-B) (Aranguren et al. 2010). Similar methods 
have also been used successfully to infect mosquitoes with virus, e.g, Chikungunya 
virus (CHIKV), in Aedes albopictus (Nuckols et al. 2013). This methodology applied 
to mosquitoes allows researchers to infect animals with pathogens (e.g., a 
nematode) delivered directly to the gut, thereby bypassing physical damage that can 
be inflicted when the pathogen is taken up per os (Klowden 1981). This is the first 
time that reverse gavage has been used as methodology to test an antiviral in 
shrimp.  
Materials and Methods 
Animal rearing  
Specific Pathogen Free (SPF) juvenile L. vannamei were received from 
Shrimp Improvement Systems (Islamorada, FL, USA) and cultured in artificial 
seawater that was prepared using sea salt (Crystal Sea Marine Mix) at animal 
rearing facility on SPF units at Iowa State University. Water quality was maintained 
at 25 to 27 °C and the salinity at 30-35 parts per thousand (ppt). Other water 
qualities such as pH, ammonia and nitrite were monitored once a week using 
commercial available kits (Nitriver3, Hach Company, Loveland, CO). Shrimp was fed 
with the commercial feed (Zeigler) until sized 3-5 grams for the study. 
Dose determination of WSSV and IMNV bioassay 
Tanks were stocked with 20 SPF shrimp (3- 5 grams) in 8 x 50 L tanks and 
allowed to acclimate for 24 hours. Each tank contained artificial seawater with oyster 
shell biofilters. WSSV dilutions of virus stock were prepared at 1:103, 1:104 and 1:105 
with 2% NaCl (WSSV stock ~ 6.8 x 106 WSSV copy numbers µl-1DNA). Shrimp were 
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challenged via intramuscular injection with 100 µl WSSV/ shrimp using the different 
dilutions. Mortality was observed for 8 days post-infection. The virus isolate used in 
this study was kindly provided by the Aquaculture Pathology laboratory, University of 
Arizona. Virus stocks were purified from macerated shrimp tissue, clarified by 
centrifugation, and filtered through 0.2 micron filter (Hasson et al. 1995). Virus 
samples were stored in aliquots at -80°C for disease challenge experiments. 
IMNV infected tissue were macerated and clarified and filtered following the 
method of (Loy et al. 2012). The virus was diluted with sterile 2% NaCl (viral diluent) 
into three different concentrations: 1:101, 1:102 and 1:103 (IMNV stock ~ 2.1 x 105 
IMNV copy numbers µl-1 RNA). Animals in each group (n= 10) were injected 
intramuscularly with 100 µl of diluted virus and mortality was observed for 14 days.  
Clinical signs of IMNV were observed at 4-5 days post-infection (p.i) and mortality 
was observed beginning on day 2 post-injection.  
Doubled-stranded RNA synthesis 
Double-stranded RNAs targeting VP19 envelope protein of WSSV (Robalino 
et al. 2005) and nucleotides 95-475 of IMNV genome (GenBank accession no. 
EF061744) were generated by in vitro transcription by adding T7 promoter to the 5’ 
end of each primers sequence and using the Megascript RNAi (Ambion) according 
to the manufacturer’s protocol. Primers that were used for dsRNAVP19 synthesis 
were VP19T7F: 5’-TAA TAC GAC TCA CTA TAG GGC GAA GCT TGG CCA CCA 
CGA CTA ACA CTC-3’ and VP19T7R: 5’-TAA TAC GAC TCA CTA TAG GGC GGA 
GCT CCT GCC TCC TCT TGG GGT AAG AC-3’. Primers for dsRNA95-475 were 
generated according to a previous publication (Loy et al. 2012). Tracking dye was 
	   126	  
prepared by mixing commercially available red food coloring (Tone’s, Ankeny IA) 
with nuclease free water in 1:103 dilution and filtered at 0.2 microns for sterility. 
Then, either dsRNAVP19 or dsRNA95-475 were mixed with sterile filtered marking 
dye to facilitate observation of dsRNA introduction into the foregut and to ensure that 
the preparation did not perforate the gut lumen during the reverse gavage 
procedure.  
 Reverse gavage injection  
SPF 3-5 gram juvenile L. vannamei were divided into 3 groups of 10 shrimp 
with 3 replicates in each group. A sham group (n=10) were injected with 2% NaCl.  
Animals were acclimated for 48 hours and starved for 24 h prior to treatment. 
Treatment groups received 2 µg/shrimp of VP19dsRNA either by reverse gavage 
(RG) as shown in Fig. 2 or via intramuscular injection (IM) at the third abdominal 
segment from the telson. RG was performed using a tuberculin syringe, with a 27G x 
½ CC needle (Becton, Dickinson and Company). A new syringe and needle were 
used to deliver 100 µl of dsRNA, mixed with tracking dye to the hindgut via the anus 
into each animal. The syringe cargo was transported (by positive pressure) through 
the midgut into the foregut (Felgenhauer, 1992), and care was taken to not puncture 
the gut epithelium. Successful delivery was indicated by visualizing the tracking dye 
translocating into the foregut. At 3 days post-dsRNAVP19 injection, shrimp in each 
treatment group, and positive control animals, were challenged with 100 µl with 0.2 
micron filtered WSSV clarification diluted in 2% sterile saline at WSSV 1:104 dilution 
(∼ 6.8 x 102 WSSV copy numbers µl-1 DNA). Mortality was observed for 21 days 
post-WSSV challenge. The WSSV study was repeated twice. The RG experiment 
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was then carried out using dsRNA95-475 at a dose of 2µg/shrimp and subsequent 
challenge with IMNV at 1:103 dilution (∼ 2.1 x 103 IMNV copy numbers µl-1 RNA) at 2 
days post-injection was observed for 14 days post-IMNV challenge and the study 
was repeated three times. Water temperatures were maintained at 27-28 °C for 
WSSV trials and at or above 30 °C for IMNV. 
Quantitative PCR of WSSV and quantitative reverse-transcription PCR of IMNV 
Dead and moribund shrimp were tested by quantitative PCR (qPCR) 
according to established protocols for the presence of WSSV (Durand & Lightner 
2002) and IMNV (Andrade et al. 2007). For WSSV, qPCR was performed on a 
BioRad CFX96 Real Time PCR Detection System. Template DNA was generated 
from gill tissues that were removed from shrimp using sterile forceps and scissors 
and nucleic acid was extracted using DNeasy Blood and Tissue kit (Qiagen) 
according to the manufacturer’s instructions. 10-50 ng (3 µl) of DNA template was 
added to 12.5 µl of PCR master mix (Quanti Tect Probe PCR Kit, Qiagen) containing 
10 µl (20 µM) of each primer (WSSV1011F and 1079R) and 0.5 µl (10 µM) of WSSV 
TaqMan probe and 7 µl of nuclease-free water for a total reaction volume of 25 µl. 
This reaction was performed in duplicate with thermocycling conditions of 95 °C for 
15 min, followed by 35 cycles of 95 °C for 15 s and 60 °C for 1 min. Virus copy 
number was calculated using CFX manager software (Bio-Rad) using a standard 
generated from a 69-bp insert plasmid as previously described (Durand & Lightner 
2002) and performed 10 fold series dilutions. Quantitative reverse-transcription PCR 
(qRT-PCR) for IMNV was performed using template RNA from muscle tissue of 
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infected animals and RT-PCR parameters according to the methods described 
previously (Loy et al. 2012).  
Statistical analysis 
Survival and virus copy number data obtained from the experiments were 
expressed as the mean ± standard error. The survival data was analyzed using one-
way ANOVA followed by Tukey’s multiple comparison test. Survival data were 
collected until the termination of experiments on day 14 for IMNV trials and day 21 
for WSSV trials. The mean log viral copy number was compared between each 
group using one-way ANOVA followed by Tukey’s multiple comparison test.  
Statistical calculations were performed using JMP 10 (SAS Institute Inc). 
Results 
In vitro titration of WSSV and IMNV 
The dose of virus given of WSSV and IMNV were established by titration in 
order to determine the challenge dose for the reverse gavage trials. SPF shrimp 
were stocked and challenged with the different dilution of WSSV and IMNV. Mortality 
was observed for 8 days p.i. for WSSV and 14 days p.i. for IMNV, the survival of 
WSSV 1:103, 1:104 and 1:105 showed 5%, 30% and 100% survival, respectively. 
The sham control also showed 100% survival. Thus, the dose that was utilized as 
WSSV challenge model is 10000-fold dilution (1:104) of WSSV stock (~ 6.8 x 102 
WSSV copy numbers µl-1 DNA) as shown in Fig. 1A. In the IMNV dose titration, 
shrimp exposed to each dilution (1:101, 1:102 and 1:103) showed 100% mortality at 
day 6, 9 and 13 p.i. The 1000-fold dilution (1:103) of IMNV stock (~ 2.1 x 103 IMNV 
copy numbers µl-1 RNA) was chosen for experiment as shown in Fig. 1B. 
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Survival of animals following dsRNAVP19 and dsRNA95-475 reverse gavage 
administration 
Animals were subjected to vaccination by injection or RG then challenged 
with WSSV or IMNV using challenge model conditions. The groups that were 
vaccinated with dsRNAVP19 by reverse gavage, intramuscular injection and positive 
control group showed a survival rate of 98.1%, 98.3% and 5.0%, respectively, at the 
end of the experimental period (21 days p.i.) (Fig. 3). Survival of the groups 
vaccinated by RG and IM were significantly different from the positive control group 
at a significance level of p<0.0001. Similarly, dsRNA95-475 vaccinated animals 
showed significant protection (p<0.0001) against IMNV administered via RG and IM 
injection account for 81.0% and 77.0% survival, respectively, compared to the 
positive control group (2.4% survival) at the end of the experimental period (14 days 
p.i.) (Fig. 4).  
Quantitative Polymerase Chain reaction 
Quantitative real time polymerase chain reaction (qPCR) or Reverse 
transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed on 
RNA (IMNV) or DNA (WSSV) extracted from six shrimp tissue samples taken from 
animals randomly selected at termination from each treatment group, in order to 
quantify WSSV and IMNV copy number. The results indicated that the mean WSSV 
copies in RG and IM vaccinated group were both significantly reduced (p<0.0001) in 
comparison to the positive control group, accounting for 3.9 x 101, 3.0 x 101 and 4.0 
x 106 WSSV copy numbers µl-1 DNA, respectively (Fig. 5A). This shows that 
vaccination by RG with dsRNAVP19 inhibits WSSV multiplication comparable to 
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vaccination by IM injection.  In the IMNV trials, the mean IMNV viral copies of shrimp 
vaccinated with dsRNA95-475 via RG and IM are 4.7 x 103, 9.9 x 103 IMNV copy 
numbers µl-1 RNA, respectively. This was statistically significant different (p=0.0001) 
from the positive control group 4.6 x 106 IMNV copy numbers µl-1 RNA (Fig. 5B).  
Discussion 
In this study, we demonstrate for the first time the use of a reverse gavage 
system to deliver antiviral vaccines to penaeid shrimp. RNAi antiviral molecules have 
been proved to show protection against viral diseases. To fully explore the capacity 
of this methodology both DNA virus (WSSV) and RNA virus (IMNV) infection model 
were used. VP19 is a major envelope protein located in ORF 182 of the WSSV 
genome that contains two putative transmembrane domains (van Hulten et al. 2002). 
dsRNA95-475 is located in ORF1, and encodes a putative RNA-binding protein 
(Poulos et al. 2006, Loy et al. 2012). These two viral gene targets were selected 
based on previous data that demonstrated the high survival of intramuscular 
vaccinated shrimp following subsequent viral challenge (Robalino et al. 2005, Loy et 
al. 2012). However, as injection administration is impractical to use in the field for 
shrimp farming, this study was undertaken as a proxy for per os vaccination, to 
demonstrate that delivery of dsRNA to gut epithelia could induce a protective 
response.  
These experiments demonstrate that the introduction of dsRNA via reverse 
gavage can elicit statistically significant (p<0.05) protection against both IMNV and 
WSSV virus-induced mortality. Delivery by this route elicits protection comparable to 
intramuscular injection that is a standard model method for vaccine delivery. These 
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data also demonstrate that gene-specific dsRNAs significantly reduce viral 
replication in vivo for both WSSV and IMNV. This provides evidence that dsRNA 
remains potent and effective after passing through the gut environment that could 
contain digestive enzymes or bacteria that can degrade the dsRNA. Previous work 
evaluating oral delivery of pellet feed coated with inactivated bacteria that expressed 
dsRNAVP28 showed 68% survival after challenge with WSSV, however it is unclear 
if the bacterial cells or some other factors provided protection (Sarathi et al. 2008b). 
The oral delivery of DNA vector encoding expression of VP28 encapsulated in 
chitosan nanoparticles also showed 85% protection against WSSV challenged at 7 
days post-feeding (Rajeshkumar et al. 2009). Recently, another oral application has 
been developed against Laem-Singh virus (LSNV) by incorporating bacterially 
expressed LSNV-dsRNA into feed, and it improves the growth of infected animals 
compared to controls (Saksmerprome et al. 2013a). Based on the information 
obtained from previous LSNV studies, delivering dsRNA into the gut by oral feeding 
is functional, reduces mortality and improves growth on peneaid shrimp. This work 
provides direct evidence that introduction of dsRNA sequences corresponding to 
viral pathogens to the shrimp foregut via reverse gavage can provide significant 
protection from virus-induced mortality. Further research should be conducted to 
maximize oral vaccine delivery with different delivery systems that are suited to a 
marine environment.  
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Fig. 1 A) L. vannamei survival post challenge with serial dilutions of WSSV including  
1:103, 1:104 and 1:105 or normal saline (sham) (WSSV stock ∼ 6.8 x 106 WSSV copy 
numbers µl-1 DNA). Mortality was observed for 8 days, n=20 animals/group. 
B) L. vannamei survival post challenge with serial dilutions of IMNV including  
1:101, 1:102 and 1:103 or sham (IMNV stock ∼ 2.1 x 105 IMNV copy numbers µl-1 
RNA). Mortality was observed for 14 days, n=10 animals/group. 
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Fig. 2. Image of reverse gavage administration demonstrated with a tracking dye.  
A) Shrimp were subjected to reverse gavage using a tuberculin syringe, 27Gauge x 
½ CC to deliver 100 µl of tracking dye into the hindgut via the anus. B) In this 
experiment, tracking dye was used to ensure that the gut epithelium was not 
punctured; successful delivery was indicated by visualizing the tracking dye 
translocating into the foregut as seen in C.  
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Fig. 3. L.vannamei mean survival (%) following administration of dsRNAVP19 via 
intramuscular injection (IM) or reverse gavage (RG). Animals were challenged 
with WSSV at 72 hours post-vaccination and were observed for 21 days post-
infection. n=60 animals/treatment.  
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Fig. 4. L. vannamei mean survival (%) following administration of dsRNA95-475 
via intramuscular injection (IM) or reverse gavage (RG). Animals were 
challenged with IMNV at 48 hours post-vaccination and were observed for 14 
days post-infection. n=90 animals/treatment.   
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Fig. 5. Confirmation of suppression of WSSV and IMNV viral replication by 
quantitative PCR. A) Gill tissue were used as template for WSSV viral copies, n=12 
samples/group. B) Muscle tissue were used as template for IMNV viral copies 
detection, n=18 samples/group. All data are presented as mean ± standard error of 
the log10 of IMNV copies.  
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CHAPTER 6: GENERAL CONCLUSIONS 
The research described in this dissertation demonstrates the interactions of 
the Pacific white shrimp, L. vannamei with two devastating viruses, WSSV and 
IMNV, by utilizing RNA interference as tool to study this interaction. Viral diseases 
are the major cause tremendous negative impacts on the shrimp farming industry. 
Efforts have been made to mitigate and control viral diseases.  To understand the 
underlying mechanisms of host-virus interactions, the transcriptome of lymphoid 
organ from shrimp infected with IMNV was analyzed. Surprisingly, we found that 
IMNV has additional sequences at both the 5’ (643 bp) and 3’ (22 bp) ends of the 
genome that results in the full-length IMNV genome sequence of 8226 bp as 
compared to the original description of 7561 bp.  An RNAi silencing bioassay, in 
which we targeted the additional sequence at 5’ end for gene suppression revealed 
the critical nature of the new sequence to produce high titer infection and associated 
disease (Chapter 2). Outbreaks of IMNV have been reported in two countries, Brazil 
and Indonesia. Previous studies from different laboratories revealed differences in 
mortality rates in bioassays. Our studies confirmed that there is a significant 
difference in virulence between these geographically distinct isolates, with a higher 
virulence in IMNV (Indonesia). Even a ten-fold higher dose of IMNV (Brazil) did not 
equal that of shrimp exposed to IMNV (Indonesia). Genome sequencing revealed 67 
nucleotides and 30 amino acid residues that are distinct between the two isolates 
(Chapter 3). Further experimentation is needed to identify the specific nucleotide 
changes that are associated with the increased virulence phenotype in IMNV 
(Indonesia).  
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WSSV is the most devastating virus in shrimp aquaculture that historically 
and currently causes the highest economic losses of all of the shrimp infectious 
diseases. Novel antiviral molecules against WSSV have been developed based on 
genes associated with the early stage of virus infection including immediate early 
(dsRNA403), early (dsRNA477) and late genes (dsRNAVP15). dsRNA477 (early 
gene) showed a significant level of protection with the lowest dose of 0.1 µg/shrimp 
following the challenge with lethal dose of WSSV. In contrast, administration of 
dsRNAVP15 (late gene) at the same dose did not provide good protection. This 
provides evidence that gene function and the stage of expression may play an 
important role in selection of RNAi targets (Chapter 4). Furthermore, these data 
have important implications in context of field application of this technology, namely 
the small dose of dsRNA477 required to induce protection will reduce the cost of 
production for an antiviral vaccine that will benefit to shrimp production systems.  
The goal of the aquaculture industry is to develop an oral vaccine that is 
suited to a marine environment. RNAi-based antiviral vaccines targeting viral genes 
on a sequence-specific level has been subject to intense research efforts for the last 
decade, and has provided some provocative and promising results for disease 
control. Development of an oral delivery system has shown some promise; however, 
a primary hurdle is a consistent vaccine delivery system.  The hypothesis that 
directly delivering of dsRNA into the gut can provide protection against viral diseases 
has not been tested robustly. In our study, a new methodology leveraging reverse 
gavage to deliver dsRNA has been developed as shown in Chapter 5 and it can be 
used as a proxy for possible per os vaccination. We show that dsRNA delivered via 
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this method elicits protection against WSSV and IMNV that is comparable to the 
traditional intramuscular injection method. These results also indicate that dsRNA 
can be taken up through the gut epithelial cells. However, further research is needed 
to identify the underlying mechanism to dsRNA uptake into shrimp gut epithelial 
cells.  
 
Future directions 
 
 Data based on in vivo bioassay studies described in this dissertation, show 
that shrimp utilize RNAi as antiviral mechanisms that can shut down virus replication 
in specific manner.  To accomplish the goal of oral vaccine development, novel 
antiviral molecules that provide a high protection against viral diseases including 
dsRNA233 (IMNV) and dsRNA477 (WSSV) should be incorporated into feed using a 
delivery technology that can improve the stability and efficacy of nucleic acids in 
marine environment. Further study of the mechanisms and functions of RNAi 
pathway in penaeid shrimp are needed in order to advance our understanding in 
antiviral immunity in invertebrates.  Shrimp immunity is a complex cellular system 
that data has shown that shrimp may possess some forms of memory immune 
response, however; further studies are needed to develop the model to study long-
term memory immune response against viral diseases. Study of host-virus 
interactions has been hampered by a lack of shrimp genome sequencing for genetic 
manipulations and immortal cell lines that can be used as a tool for in vitro studies.  
 The research presented in this dissertation significantly advances knowledge 
of the host-virus interactions in the Pacific white shrimp and provides promising 
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results toward oral vaccine development. There is a rich landscape of research 
questions yet to be addressed from the fundamental mechanisms of RNAi pathway 
in penaeid shrimp to further advances vaccine development, all of which would 
prove useful in developing new shrimp disease control strategies. 
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